Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,insulin-like growth factor I binding (GO:0031994),-0.8632209291865285,-2.034756792249664,0.0,0.004239318759907104,0.004,9/13,11.22%,IGFBP2;IGFBP5;ITGA6;IGF1R;IGFBP6;IGFBP4;IGFBP3;ITGB4;ITGB3
prerank,inward rectifier potassium channel activity (GO:0005242),0.8275796777969577,2.032316446536323,0.0,0.05206908251157395,0.045,3/24,1.12%,ABCC9;KCNJ8;KCNJ12
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.8545618903292944,2.019930916988176,0.0,0.03502829187142247,0.064,7/23,2.42%,PDE8B;PDE4D;PDE4C;PDE3A;PDE5A;PDE7B;PDE9A
prerank,retinoid binding (GO:0005501),-0.7525988289103825,-2.010818702884874,0.0,0.004239318759907104,0.007,7/22,9.70%,ALDH1A2;RBP1;PTGDS;CYP26B1;RBP4;ABCA4;CRABP2
prerank,store-operated calcium channel activity (GO:0015279),0.9327701879501219,2.0076565618295996,0.0,0.03502829187142248,0.09,4/10,1.23%,TRPC3;TRPC4;TRPC6;TRPC1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.8621070337631371,2.007157361740019,0.0,0.0269812518469065,0.091,7/21,2.42%,PDE8B;PDE4D;PDE4C;PDE3A;PDE5A;PDE7B;PDE9A
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.7235737765556968,-2.002886446633809,0.0,0.0035327656332559197,0.009,8/25,6.03%,MICAL3;POR;MICAL2;CYP26B1;NOS3;FMO1;FMO2;CYP27A1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.9137028827627505,1.9743280482238215,0.0,0.04866092438354365,0.197,7/11,5.55%,TRPC3;TRPC4;TRPC6;TRPC1;ITPR2;ITPR1;RPH3A
prerank,cyclic nucleotide binding (GO:0030551),0.8284761135473118,1.9683953998216113,0.001953125,0.0471777444574564,0.225,7/21,6.49%,PDE4D;RAPGEF2;RAPGEF4;PDE5A;SLC19A1;PDE4B;POPDC3
prerank,calcium channel activity (GO:0005262),0.6555961503942017,1.9564876173305905,0.0,0.052474815622053736,0.277,12/84,4.63%,TRPC3;TRPC4;TRPC6;CACNA1C;CACNB2;TRPC1;TRPV2;CACNG7;CACNA2D1;STIM2;SLC24A4;SLC24A2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.9260192215326337,1.954121030629035,0.0,0.047572207203756205,0.285,5/12,2.18%,PDE8B;PDE4D;PDE4C;PDE3A;PDE7B
prerank,cation channel activity (GO:0005261),0.651079240567343,1.9465420542909968,0.0,0.04922895073821537,0.313,17/94,7.60%,ABCC9;TRPC3;ANO1;TRPC6;CACNB2;TRPC1;KCNG1;TRPV2;KCNQ4;UNC80;SLC24A4;SLC24A2;TMEM38B;RYR2;CHRNA7;CACNA1D;TMEM38A
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.6845755289279896,1.9432775061039307,0.0017006802721088435,0.04752487167420023,0.337,15/55,7.38%,TRPC3;CACNB2;ATP2A3;TRPC1;ITPR2;TRPV2;ATP2C1;ATP2B3;ITPR1;SLC24A4;SLC24A2;RYR2;ATP2A2;CHRNA7;CACNA1D
prerank,glutamate receptor activity (GO:0008066),0.8421511874648566,1.9420437269806994,0.0020325203252032522,0.044839656179388475,0.343,7/19,5.80%,GRM3;GRM7;GRIK1;GRM5;GRM1;GRID1;GRIA2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.8144099918298543,-1.9019074381845664,0.0,0.02331625317948907,0.074,7/12,6.10%,TGFBR3;TGFBR2;BMPR2;TGFBR1;ACVR1;LTBP4;ACVRL1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.765948918638441,-1.8677979579646766,0.001838235294117647,0.03518634570722896,0.137,6/15,12.87%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1;ALDH3A2
prerank,glucuronosyltransferase activity (GO:0015020),-0.7242254617591294,-1.862460105795373,0.0,0.03250144382595446,0.153,4/19,5.32%,EXT1;LARGE1;CSGALNACT1;CHSY1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.8246884649574616,1.8611143453419106,0.004132231404958678,0.12889828817550472,0.733,2/16,0.25%,ANO1;ANO4
prerank,intracellular chloride channel activity (GO:0061778),0.8246884649574616,1.8611143453419106,0.004132231404958678,0.12889828817550472,0.733,2/16,0.25%,ANO1;ANO4
prerank,ion gated channel activity (GO:0022839),0.7555843030090208,1.85712858315362,0.003669724770642202,0.12740019669065625,0.755,2/24,0.25%,ANO1;ANO4
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7351224640165244,1.8480763112433707,0.003787878787878788,0.135884526845356,0.795,9/31,9.95%,ABCC9;SLC12A2;KCNG1;KCNQ4;SLC12A6;TMEM38B;TMEM38A;PKD2;SLC12A5
prerank,cAMP binding (GO:0030552),0.8707584173489953,1.8240628752699617,0.006355932203389831,0.16638438638925676,0.872,5/11,6.49%,PDE4D;RAPGEF2;RAPGEF4;PDE4B;POPDC3
prerank,I-SMAD binding (GO:0070411),-0.7589696680085787,-1.8028455275980098,0.001876172607879925,0.07615633343690262,0.355,6/13,6.13%,SMAD3;SMAD6;TGFBR1;SMAD9;SMAD7;SMURF1
prerank,cGMP binding (GO:0030553),0.8371955718533812,1.790786488075806,0.010683760683760684,0.22108476745555994,0.947,2/11,1.66%,RAPGEF2;PDE5A
prerank,potassium channel regulator activity (GO:0015459),0.6408057576859323,1.772328660204019,0.012237762237762238,0.24819595997183583,0.968,6/49,5.48%,ABCC9;NEDD4L;KCNMB1;KCNE4;DPP10;KCNAB3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.7543869857263621,-1.7643106890615736,0.0036363636363636364,0.114726563939986,0.515,6/13,12.87%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1;ALDH3A2
prerank,anion channel activity (GO:0005253),0.6144075331694253,1.7544870255342853,0.0,0.277984125676623,0.983,7/61,5.87%,ANO1;ANO4;SLC1A4;GPR89A;GPR89B;GABRG2;GABRA2
prerank,voltage-gated chloride channel activity (GO:0005247),0.8197272929412285,1.7498101336611085,0.023965141612200435,0.2752087688384463,0.986,1/10,0.04%,ANO1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.693843591000985,-1.745779134255648,0.002044989775051125,0.13059456957602716,0.605,9/18,11.59%,TGFBR3;SMAD3;SMAD6;TGFBR2;TGFBR1;SMAD7;FKBP1A;USP15;TGFB1
prerank,cholesterol transfer activity (GO:0120020),-0.6927977454635992,-1.737877394739335,0.011764705882352941,0.1285573413941829,0.644,7/16,17.78%,ABCA1;PLTP;GRAMD1C;GRAMD1A;NPC2;STARD4;STARD5
prerank,voltage-gated anion channel activity (GO:0008308),0.7737881350063451,1.7373953263935547,0.022271714922048998,0.2912262104110543,0.988,3/15,4.65%,ANO1;GPR89A;GPR89B
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.6658806331420764,-1.735163940845865,0.005836575875486381,0.1207242365037182,0.652,7/18,6.10%,TGFBR3;TGFBR2;BMPR2;TGFBR1;ACVR1;LTBP4;ACVRL1
prerank,diacylglycerol kinase activity (GO:0004143),0.7974193329549345,1.7341662627294498,0.029661016949152543,0.2852180817245555,0.989,3/11,1.88%,DGKB;DGKH;DGKG
prerank,metalloendopeptidase activity (GO:0004222),-0.5018739349500722,-1.7320657251158287,0.0,0.11516815964414298,0.668,25/76,16.09%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;ADAMTS9;ADAMTS5;ADAM9;ADAM10;ADAMTS1;ADAMTS15;ADAMTSL1;ADAMTSL4;MMP14;IDE;MMP19;ADAMTS14;ADAMTS3;SPG7;ADAM33;MMP2;AFG3L2;ADAMTSL5
prerank,calcium activated cation channel activity (GO:0005227),0.7679994152610459,1.7284329627307975,0.02,0.28623588915848636,0.992,2/17,2.25%,ANO1;KCNMB1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.7922381545279245,1.72749756621784,0.0321285140562249,0.2761633686844919,0.992,7/13,7.50%,PIP5K1B;PIK3CD;PIP4K2A;PIK3CA;PIP4K2C;PIK3C2A;PIKFYVE
prerank,transforming growth factor beta binding (GO:0050431),-0.6385447773230407,-1.72438357881918,0.008583690987124463,0.11780414630895701,0.699,13/23,23.75%,TGFBR3;TGFBR2;THBS1;TGFBR1;ACVR1;LTBP4;ACVRL1;TWSG1;LTBP1;CD109;LRRC32;NRROS;LTBP3
prerank,potassium channel activity (GO:0005267),0.5806388881405385,1.7192055864240396,0.007987220447284345,0.28348301940483095,0.994,18/89,9.02%,ABCC9;KCNG1;KCNMB1;KCNV2;KCNQ4;GRIK1;KCND2;KCNH8;KCNH4;TMEM38B;KCNQ5;HCN2;TMEM38A;KCNE5;KCNA4;KCNQ3;HCN3;PKD2
prerank,chloride channel activity (GO:0005254),0.6036425841425085,1.7174486696102207,0.006920415224913495,0.27625743287784027,0.995,7/59,6.37%,ANO1;ANO4;SLC1A4;TTYH2;GABRG2;GABRA2;TTYH1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.7575150528807645,-1.7157689411334107,0.010714285714285714,0.1211990952609156,0.735,4/11,2.79%,AKAP13;SH3RF1;IQGAP1;KSR1
prerank,P-type ion transporter activity (GO:0015662),0.7765672010428881,1.7100230106944065,0.029885057471264367,0.2802263349713798,0.997,5/12,6.59%,ATP2A3;ATP2C1;ATP7A;ATP2B3;ATP2A2
prerank,insulin-like growth factor binding (GO:0005520),-0.6953233529440298,-1.7087650197291693,0.005747126436781609,0.12202172497265946,0.758,9/15,11.22%,IGFBP2;IGFBP5;ITGA6;IGF1R;IGFBP6;IGFBP4;IGFBP3;ITGB4;ITGB3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.6194763027792018,1.7044361047983823,0.012259194395796848,0.2822211894312388,0.997,7/48,4.77%,ABCC9;TRPC6;SLC12A2;TRPC1;TRPV2;UNC80;SLC12A6
prerank,sterol transfer activity (GO:0120015),-0.6677907755469485,-1.7018891864702428,0.009861932938856016,0.12466246728351828,0.786,9/17,24.63%,ABCA1;PLTP;GRAMD1C;GRAMD1A;NPC2;STARD4;STARD5;OSBP;GRAMD1B
prerank,G protein-coupled receptor activity (GO:0004930),0.4980466940811903,1.6975007810048053,0.0,0.287800019700336,0.998,25/239,6.60%,GRM3;PDGFRB;CYSLTR2;P2RY14;S1PR3;PTH1R;ADGRL3;RORB;ADORA2A;GPR61;GPR152;ADCYAP1R1;FFAR2;GIPR;OPN1MW;OPN1MW3;GRM5;GPR87;XPR1;TAS1R1;GRM1;CXCR2;GPR45;TRHR;OPRK1
prerank,leak channel activity (GO:0022840),-0.6707724558229591,-1.6944199752802243,0.00784313725490196,0.12805236371837045,0.808,3/18,2.80%,KCNK2;NALCN;KCNK5
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.6567137861567017,1.6787208600654837,0.018518518518518517,0.3185996709314246,0.998,6/34,5.31%,MYO1B;ADAP2;FERMT2;ARAP2;CYTH3;OGT
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6394986894323468,-1.6732172843819384,0.015533980582524271,0.15396970218273717,0.874,7/18,5.49%,PDLIM5;BAIAP2L1;STXBP6;ANXA2;BAIAP2;ANXA1;CNN3
prerank,SH2 domain binding (GO:0042169),0.6558184974726093,1.6661226728923129,0.026871401151631478,0.3350133930510066,0.998,4/31,3.86%,DLC1;PTK2;AFAP1L2;PAG1
prerank,semaphorin receptor activity (GO:0017154),-0.7261163488732735,-1.665750710281725,0.010948905109489052,0.1566874525865665,0.891,4/11,2.27%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,gap junction channel activity (GO:0005243),0.6809667248802052,1.654261551258224,0.04554455445544554,0.3509929516575644,1.0,4/22,6.35%,GJD3;GJC1;GJA4;GJC2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.39946697286325694,-1.6499376966580717,0.0,0.17762745604010766,0.925,73/254,18.12%,NFIB;SMAD3;ZBTB16;MECOM;NFAT5;FOXO1;FOXO3;NFIA;NR3C1;ERG;HOXB3;MLXIP;ESR1;ELF1;ELF4;MEOX2;KLF4;PLAGL1;TCF4;FOXC2;TFDP2;NFATC1;LEF1;HOXA5;AR;PRRX1;GLIS2;GTF2I;IRF1;SIX1;HLF;PRDM16;FOXC1;IRF2;STAT3;HINFP;NR2C2;PGR;KLF10;TFCP2;RREB1;HIF1A;NR4A2;ATF6;FOSL2;TFCP2L1;CEBPG;NFYC;ELK3;MDM2;ZIC3;RELA;PPARA;MEF2A;CLOCK;MEIS2;ZNF585A;ZNF585B;SOX17;HSF2;CREB3L1;HOXC4;HOXB7;CREB3;NKRF;HHEX;MEIS1;SOX18;ATF1;NFYB;MAFF;SOX12;KLF15
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7614567278370721,1.649249040600185,0.054279749478079335,0.35263535109215816,1.0,4/11,9.41%,KCNJ8;KCNE4;KCNE5;KCNJ3
prerank,wide pore channel activity (GO:0022829),0.6781366867484663,1.649182783208821,0.04590818363273453,0.34234725640631103,1.0,4/23,6.35%,GJD3;GJC1;GJA4;GJC2
prerank,frizzled binding (GO:0005109),-0.5585209191029454,-1.646697101290028,0.00663716814159292,0.1745690903633175,0.931,16/34,17.61%,WNT4;WNT6;LRP6;WNT9A;RNF43;SDCBP;WNT5A;FZD7;ZNRF3;MYOC;WNT5B;CCDC88C;WNT16;SFRP1;WNT11;FZD1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7939428195184061,1.645611063710222,0.041304347826086954,0.3407076173069015,1.0,2/10,0.73%,CACNA1C;CACNB2
prerank,phospholipase C activity (GO:0004629),0.6753424572420244,1.644644652338992,0.043478260869565216,0.3335051032382731,1.0,3/25,0.48%,PLCL1;EDNRA;PLCE1
prerank,LRR domain binding (GO:0030275),-0.6736640463275871,-1.640224870418318,0.028790786948176585,0.17819591014654973,0.94,4/14,9.13%,ROBO1;PAWR;ERC1;PMF1
prerank,filamin binding (GO:0031005),-0.7254452902873112,-1.624230211904901,0.02112676056338028,0.19823423157739523,0.967,3/11,5.35%,NEBL;DPYSL3;SYNPO2
prerank,calcium channel regulator activity (GO:0005246),0.6320979758558687,1.6234400630559478,0.027777777777777776,0.3723131300373035,1.0,7/37,3.94%,REM1;PRKG1;RRAD;NRXN1;CACNG7;STIM2;ITPR1
prerank,chemokine binding (GO:0019956),0.6453169329402493,1.6216620601472536,0.043478260869565216,0.36655139281951554,1.0,8/30,8.20%,ITGA4;CCRL2;ACKR3;FGF2;ITGB1;CXCR2;ACKR2;CCR9
prerank,metal ion transmembrane transporter activity (GO:0046873),0.6671612705639609,1.6211701548668846,0.04854368932038835,0.35831782142346996,1.0,5/27,3.94%,SLC12A2;ATP2A3;ITPR2;ATP2B3;ITPR1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5886662431800912,-1.6168579382381982,0.00992063492063492,0.20397305575011368,0.976,8/24,10.42%,PLA2G4A;OSBPL8;CERT1;SESTD1;ARFIP2;GOLPH3;DAB2IP;GSDMD
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.4982106173844672,-1.6083531000497313,0.004842615012106538,0.21209311755815238,0.98,19/53,18.75%,MICAL3;AOX1;POR;DDO;MICAL2;XDH;NOS3;DPYD;PRODH;AIFM1;ACOX1;ACADL;PPOX;ACOX3;NOS1;SQOR;ILVBL;QSOX1;CYB5R3
prerank,ion channel activity (GO:0005216),0.5454272291399543,1.606112887086323,0.020700636942675158,0.3815717037507251,1.0,10/80,6.61%,ABCC9;TRPC6;TRPC1;TRPV2;CHRNA3;UNC80;GRIK1;GRID1;GRIA2;CHRNA7
prerank,exopeptidase activity (GO:0008238),0.5833547156894135,1.6060480072662535,0.02867383512544803,0.37249598185219995,1.0,9/50,5.28%,ACE2;ENPEP;FAP;NAALAD2;CPM;METAP2;ANPEP;GGH;DPP10
prerank,phospholipase inhibitor activity (GO:0004859),-0.7040960515658905,-1.5862189141921552,0.025048169556840076,0.2510573484833447,0.995,4/10,3.96%,ANXA4;ANXA5;ANXA2;ANXA1
prerank,GTPase regulator activity (GO:0030695),0.4731621452726677,1.5829643299024447,0.012379642365887207,0.4153354607611522,1.0,31/212,5.01%,DLC1;RGS5;STARD8;CHN1;ARHGAP42;RGS6;TBC1D1;ARHGAP10;RAPGEF2;ARHGAP32;ARHGEF6;PREX2;ARHGAP1;RASGRP3;SIPA1;NF1;AGAP2;WAS;RGS3;STARD13;SH3BP1;GRTP1;GARNL3;WASL;RIMS1;RGS11;RTKN;ASAP2;TBC1D30;RIN2;SYDE1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.6306823122348434,-1.5813361306242097,0.02095238095238095,0.2530245252440851,0.997,5/18,16.31%,ALDH1A1;ALDH1A2;AKR1B1;ALDH3A2;FAR2
prerank,NAD binding (GO:0051287),-0.5739497780440846,-1.5808425636822265,0.020242914979757085,0.24482065838463524,0.997,11/26,20.05%,ALDH1A1;CRYL1;PARP9;SORD;ME1;NNT;BDH2;SIRT2;SIRT3;HSD17B8;NUDT6
prerank,phosphatidic acid binding (GO:0070300),0.6815510732470552,1.580617440167204,0.06463878326996197,0.41179709061161907,1.0,3/19,1.89%,PITPNC1;RAPGEF2;MARK1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.686207104584141,-1.5704412726538521,0.026217228464419477,0.26009682426085223,0.997,7/12,13.98%,SULF1;ARSB;SULF2;ARSI;ARSK;ARSG;GALNS
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.4555672013548428,-1.5670980279466544,0.0,0.25944630810631475,0.997,27/78,15.98%,CTSH;CASP12;USP47;CAPN2;CTSC;CFLAR;USP46;CASP4;USP12;USP8;CAPNS1;USP15;USP18;CTSB;CAPN5;CAPN1;USP34;CASP8;USP35;USP11;USP5;GPAA1;CTSS;USP49;SFRP1;PDIA3;CASP6
prerank,GTPase activator activity (GO:0005096),0.44769182473136043,1.566233716663581,0.0,0.43591719491094555,1.0,39/313,5.01%,DLC1;RGS5;STARD8;CHN1;ARHGAP42;RAPGEF5;RGS6;TBC1D1;PLCE1;ARHGEF17;ARHGAP10;DOCK10;KALRN;RAPGEF2;DENND2A;RAPGEF4;ARHGAP32;FARP1;ARHGEF6;RASGRP2;PREX2;ARHGAP1;RASGRP3;SIPA1;NF1;AGAP2;RGS3;STARD13;SH3BP1;GRTP1;GARNL3;RGS11;RALGPS1;CYTH3;ASAP2;EPS8L1;TBC1D30;RIN2;SYDE1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.7008764219586947,1.5632382571373464,0.08118811881188119,0.4332358045094313,1.0,4/14,9.40%,PTEN;MTMR12;MTMR14;MTMR7
prerank,carboxylic acid binding (GO:0031406),0.6084118608328962,1.5614204989472433,0.04158790170132325,0.4279543485160746,1.0,3/38,2.38%,GRM7;UBR1;SESN3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6290648933742671,1.5571404676090392,0.05859375,0.4284973277635252,1.0,11/28,14.68%,CHRNA3;GRIK1;GABRG2;GRID1;GABRA2;CHRNA7;GABRA5;GABRA4;GRIK5;GRIK2;CHRNB2
prerank,solute:anion antiporter activity (GO:0140323),-0.6378488813765074,-1.5428468909189155,0.03333333333333333,0.30830787561969564,1.0,3/14,2.95%,SLC7A11;SLC26A7;SLC26A2
prerank,FAD binding (GO:0071949),-0.5525156525745799,-1.5402966460870489,0.039337474120082816,0.30533030974674674,1.0,8/24,18.75%,MICAL3;DDO;MICAL2;PRODH;AIFM1;SQOR;QSOX1;CYB5R3
prerank,potassium ion leak channel activity (GO:0022841),-0.6273142915918021,-1.5304802802625832,0.028462998102466792,0.32177071708719146,1.0,2/15,2.80%,KCNK2;KCNK5
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.5271285314709448,-1.5282477491066397,0.02564102564102564,0.3181047643003823,1.0,13/29,20.56%,PTPRJ;NFATC1;ACE;MAPK14;DUSP1;DUSP16;GCH1;DUSP7;MAPKAPK3;DUSP10;TPR;ATF7;CDK5RAP3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.523288620609615,1.526488030969791,0.05379746835443038,0.4930784328747533,1.0,9/73,8.13%,EDNRA;CYSLTR2;PTH1R;ADCYAP1R1;GIPR;SORCS1;NPSR1;OPRK1;GPR37
prerank,leucine zipper domain binding (GO:0043522),-0.6786768965331265,-1.526101297653776,0.04918032786885246,0.31395183501940604,1.0,3/10,9.13%,PAWR;ERC1;PMF1
prerank,ephrin receptor activity (GO:0005003),-0.5957235619231864,-1.5256545469507705,0.03377110694183865,0.2981272273858996,1.0,6/17,12.29%,EPHA4;EPHA3;EPHA7;EPHB4;EPHA8;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5957235619231864,-1.5256545469507705,0.03377110694183865,0.2981272273858996,1.0,6/17,12.29%,EPHA4;EPHA3;EPHA7;EPHB4;EPHA8;EPHB2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6156503897954362,1.52441350025668,0.07707509881422925,0.48846402376905845,1.0,4/27,5.36%,ANO1;XPR1;SLC22A8;SLC26A1
prerank,bHLH transcription factor binding (GO:0043425),-0.5870827204589405,-1.5157088267111558,0.026584867075664622,0.3136816979781263,1.0,7/19,16.68%,SMAD3;FHL2;BHLHE40;LMO2;BHLHE41;USF1;USF2
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6686776467825324,-1.5114983206981982,0.043243243243243246,0.3163999251384513,1.0,4/11,8.73%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6490136801999625,1.4973744034428493,0.11487758945386065,0.5450402215193336,1.0,4/16,9.40%,PTEN;MTMR12;MTMR14;MTMR7
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6613667067349422,-1.486987128803901,0.046992481203007516,0.3710198787186198,1.0,3/10,8.73%,SLC6A13;SLC6A12;SLC6A1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.618217790851279,1.4828785234049788,0.08739837398373984,0.571831759988961,1.0,7/21,16.17%,CHRNA3;GRM5;GRM1;CHRNA7;CHRFAM7A;CHRNB2;GRIA1
prerank,R-SMAD binding (GO:0070412),-0.5798622125069124,-1.4818616445511403,0.04878048780487805,0.37608444291395393,1.0,5/18,6.13%,LDLRAD4;SMAD3;SMAD6;DDX5;SMURF1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5995533633087414,1.481430340062941,0.10940499040307101,0.5650041631692957,1.0,2/25,0.90%,ART3;PARP8
prerank,cytochrome-c oxidase activity (GO:0004129),0.6603151932386919,1.468962365501964,0.12448132780082988,0.5859602685110367,1.0,2/15,1.21%,COX4I2;NDUFA4L2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.5466212543421393,-1.4689497789698835,0.04397705544933078,0.4033913672373509,1.0,13/22,31.44%,DUSP1;DUSP12;DUSP16;DUSP7;DUSP10;DUSP23;MTMR3;DUSP15;PPM1F;DUSP8;DUSP4;CDKN3;DUSP18
prerank,AMP binding (GO:0016208),-0.6483962519096316,-1.4645799495155782,0.053604436229205174,0.40547112162344046,1.0,2/11,3.00%,PRKAG2;MPPED2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6030626195404176,-1.4626344268937874,0.06177606177606178,0.40203675807732653,1.0,2/14,1.30%,SLC7A11;SLC1A3
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6147998883082729,-1.46130440370142,0.0670391061452514,0.3966353735310863,1.0,4/13,3.24%,BMP6;CDH5;BMP7;BMP4
prerank,C-C chemokine receptor activity (GO:0016493),0.613635802088786,1.4603755505575584,0.10982658959537572,0.5971464711874479,1.0,5/21,8.20%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.600695797866436,-1.454042666263154,0.07392197125256673,0.4079422715375825,1.0,6/14,23.72%,CAPN2;CAPNS1;CAPN5;CAPN1;CAPN6;CAPN15
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6540880059748957,1.4509906486234465,0.12629399585921325,0.6121430682178857,1.0,4/14,9.41%,KCNJ8;KCNE4;KCNE5;KCNJ3
prerank,amino acid binding (GO:0016597),0.5768099990151221,1.4463080478341197,0.09833024118738404,0.6141108738037128,1.0,1/31,0.09%,GRM7
prerank,chloride channel inhibitor activity (GO:0019869),-0.6519390074669585,-1.446241761965107,0.09328358208955224,0.421631820067782,1.0,4/10,10.34%,WNK4;STX7;WNK1;STX1A
prerank,poly(A) binding (GO:0008143),0.624766129272016,1.444087918999587,0.10865191146881288,0.608585429470205,1.0,9/21,13.28%,RBPMS;RBMS3;ELAVL4;HNRNPDL;DDX3X;RBMS1;KHDRBS2;PABPC4;HNRNPU
prerank,voltage-gated potassium channel activity (GO:0005249),0.4896471521368303,1.4426105191776704,0.07606973058637084,0.6021732263376132,1.0,21/80,12.95%,KCNJ8;KCNJ12;KCNG1;KCNV2;KCNQ4;KCNE4;KCND2;KCNH8;KCNH4;KCNQ5;HCN2;KCNE5;KCNA4;KCNQ3;HCN3;PKD2;KCNJ3;KCNJ6;KCNC4;KCNG2;KCNMA1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6263972558752281,1.4424639671163353,0.13,0.5922717733697092,1.0,8/19,12.33%,GRIK1;GABRG2;GRID1;GABRA2;GABRA5;GABRA4;GRIK5;GRIK2
prerank,nucleotide diphosphatase activity (GO:0004551),-0.6102734459949984,-1.4406909087198267,0.0670611439842209,0.4306220509086887,1.0,8/14,20.86%,ENPP1;FHIT;NUDT4;NUDT3;NUDT12;NUDT13;NUDT6;CILP
prerank,death domain binding (GO:0070513),-0.6276524267840734,-1.440050605550671,0.07142857142857142,0.42354255079847397,1.0,9/11,30.76%,DAP;MCL1;IRGM;DAPL1;RIPK1;BCL2L1;RACK1;CRADD;TRADD
prerank,muscle alpha-actinin binding (GO:0051371),-0.5918240941748584,-1.4398322829799635,0.060263653483992465,0.41570759759649056,1.0,5/15,6.00%,PDLIM5;PALLD;SYNPO2;PDLIM7;PDLIM2
prerank,voltage-gated cation channel activity (GO:0022843),0.47870309195768634,1.437885526606512,0.06376360808709176,0.5938399967895749,1.0,20/97,9.86%,CACNA1C;CACNB2;KCNG1;KCNV2;KCNQ4;CACNG7;CACNA2D1;KCND2;KCNH8;KCNH4;KCNQ5;HCN2;CACNA1D;KCNE5;KCNA4;KCNQ3;HCN3;PKD2;GRIN2B;CACNA1A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.535032452591856,-1.4367201587142717,0.06041666666666667,0.41638838231499326,1.0,7/24,15.00%,DAPK1;CAMK1D;PHKA2;PTK2B;CAMK2A;MKNK2;MAPKAPK3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.6181507721193278,-1.431571839544674,0.07678244972577697,0.4229739530016929,1.0,6/12,11.22%,CDH5;ITGA5;VEGFD;VEGFC;DAB2IP;ITGB3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6085587444584765,1.4315244447809299,0.1083844580777096,0.6008973879830463,1.0,4/19,4.09%,AFAP1L2;NRG1;GRM5;NRG3
prerank,phosphatidylglycerol binding (GO:1901611),0.6488947489743363,1.4303079896126984,0.13991769547325103,0.5943968254920935,1.0,1/13,0.15%,PITPNC1
prerank,BMP receptor binding (GO:0070700),-0.6148019060504535,-1.4301277891487838,0.07007575757575757,0.41845275646139646,1.0,4/12,3.24%,BMP6;CDH5;BMP7;BMP4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.6098136236852444,-1.4281542317217963,0.081374321880651,0.4155906238010783,1.0,7/12,18.39%,TAF1;STAT1;H3-3A;HDAC1;RELA;POU2F1;TBPL1
prerank,alpha-tubulin binding (GO:0043014),0.5600153056768373,1.4180719287786783,0.11428571428571428,0.6152416670097722,1.0,3/31,6.29%,DLEC1;ARL4C;SNCA
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.3093475888558291,-1.414655725694067,0.0,0.4469398150785699,1.0,174/732,16.16%,NFIB;FOXP2;PBX1;PKNOX2;FOXN3;ZNF423;MAF;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;NFATC1;LEF1;KLF2;THRB;MXI1;HOXA5;SKI;ZNF23;HOXA3;ZNF697;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;TFCP2;IRF9;ZBTB18;FOXL1;RREB1;HIF1A;MKX;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;AHR;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;HMGB2;SOX18;KDM6B
prerank,voltage-gated calcium channel activity (GO:0005245),0.556928060482657,1.412852185460988,0.12966601178781925,0.6182316007070232,1.0,8/37,9.86%,CACNA1C;CACNB2;CACNA1H;CACNG7;CACNA2D1;CACNA1D;PKD2;CACNA1A
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.6197977696387106,-1.408657094829597,0.0838095238095238,0.4568244474403468,1.0,4/11,19.48%,SLC25A20;SLC22A4;SLC22A5;SLC25A29
prerank,beta-tubulin binding (GO:0048487),0.5586761467577125,1.404484909190185,0.11900191938579655,0.6300431807792073,1.0,3/31,6.72%,DLEC1;FGF13;APPL1
prerank,C-C chemokine binding (GO:0019957),0.5872378090456382,1.4032608220665581,0.1343570057581574,0.6235810534505934,1.0,5/22,8.20%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4807122547017255,-1.4011566965082782,0.06868686868686869,0.470694536873019,1.0,15/35,22.86%,FOXP1;NR3C1;TAF1;STAT1;H3-3A;KLF10;HDAC1;RELA;POU2F1;PARK7;TBPL1;AGO1;UBTF;PIH1D1;SMARCA4
prerank,mannosyltransferase activity (GO:0000030),-0.5152013011111444,-1.3991431735702389,0.09867172675521822,0.46857263344955974,1.0,3/21,4.87%,TMTC1;TMTC4;TMTC2
prerank,death receptor activity (GO:0005035),-0.5984569279402054,-1.397381693725252,0.09689922480620156,0.4654987556959012,1.0,9/11,35.84%,TNFRSF1B;TNFRSF19;TNFRSF1A;TNFRSF11A;EDA2R;FAS;TNFRSF14;TNFRSF10B;TNFRSF25
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.3072809581933878,-1.394539257107647,0.0,0.4659011317137907,1.0,175/731,16.16%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;NFATC1;LEF1;KLF2;TRIM24;THRB;MXI1;HOXA5;CREB3L2;SKI;ZNF23;HOXA3;ZNF697;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;TFCP2;IRF9;ZBTB18;FOXL1;RREB1;HIF1A;MKX;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;AHR;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;CREB3L1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;SOX18;KDM6B
prerank,adenyl ribonucleotide binding (GO:0032559),0.3972540900211201,1.3944937719840491,0.03201024327784891,0.6363732073470166,1.0,48/291,10.41%,MYO1B;PDE4D;KCNJ8;MAP3K20;RAPGEF2;CDK6;RAPGEF4;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;AGAP2;AKT3;RPS6KA4;SLC19A1;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;MINK1;CLP1;SYN2;RRM1;PDE4B;SYN1;POPDC3;SIK1;MCM6;LIG4;PAPOLA;HSPA14;PEX1;STK3;MYO6;MARK2;MAP4K4;GCK;MAP4K1;COQ8A;NEK6;ABCF3;DARS2;DYRK3
prerank,protease binding (GO:0002020),-0.37637929054683034,-1.391511470127435,0.03287671232876712,0.4671069051643544,1.0,25/99,11.49%,TIMP3;COL1A2;FN1;COL3A1;COL1A1;VWF;LCOR;CCBE1;F3;SLC2A13;DPP4;ANXA2;TIMP2;CFLAR;ITGA3;RNF139;BDKRB2;AMFR;CST3;ADAMTSL4;ECM1;PSAP;BRCA2;ITGB3;ATP9A
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.6615586924761067,1.3913516288911925,0.15625,0.6349365179205457,1.0,4/10,11.92%,GABRG2;GABRA2;GABRA5;GABRA4
prerank,adrenergic receptor binding (GO:0031690),0.6286015484769091,1.388396176595159,0.17584745762711865,0.6329240517151268,1.0,3/16,6.00%,PDE4D;RAPGEF2;UCHL1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5333178136526374,1.3855055387461301,0.09778597785977859,0.6311584266623722,1.0,4/35,4.62%,PLCL1;PLCE1;PLD6;GPCPD1
prerank,carboxypeptidase activity (GO:0004180),0.541001673411243,1.3851998171492805,0.12260536398467432,0.6229889047645987,1.0,3/35,0.96%,ACE2;NAALAD2;CPM
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5738547042480338,1.3851121277830258,0.15789473684210525,0.6144677686694126,1.0,2/25,3.21%,ADAP2;NCF1
prerank,vinculin binding (GO:0017166),0.6606859890859337,1.3842646844719095,0.15450643776824036,0.6079697604340191,1.0,3/11,3.97%,UTRN;DMD;CORO2B
prerank,peptidase inhibitor activity (GO:0030414),-0.4549004087367426,-1.3807327592527874,0.09071274298056156,0.4914361896313279,1.0,6/33,7.95%,RECK;CAST;TIMP2;ITIH2;SERPIND1;CST3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5728172635354465,1.3803260554818637,0.14173228346456693,0.6097711743855403,1.0,2/23,0.48%,EDNRA;PLCE1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5938468785111773,1.3798708144594998,0.1491395793499044,0.6026507166909273,1.0,10/22,13.64%,CACNA1H;SCN2A;SCN5A;HCN2;SCN8A;HCN3;SCN9A;PKD2;SCN2B;SCN1A
prerank,purinergic nucleotide receptor activity (GO:0001614),0.6093346527385568,1.378160026006804,0.17695473251028807,0.5988816459112298,1.0,2/15,4.03%,P2RY14;GPR87
prerank,cAMP response element binding (GO:0035497),-0.6185088999359669,-1.3768554014082923,0.109375,0.4949236425256627,1.0,7/10,28.98%,CREB5;CREB3L2;CREB3L1;ATF7;NR4A3;ATF2;JUN
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.4211611494496089,-1.375157577136525,0.05442176870748299,0.49209217292734175,1.0,20/54,19.40%,HDAC4;HDAC8;TGM2;HDAC9;ACER2;ASPA;NAAA;ACER3;UPB1;ASPG;GLS;ASRGL1;HINT1;HDAC1;HDAC5;NIT2;SIRT7;SIRT2;NIT1;NGLY1
prerank,lysophospholipase activity (GO:0004622),-0.5306255165670104,-1.3747823463923141,0.10559006211180125,0.4856465740916657,1.0,11/20,24.87%,PLA2G4A;ASPG;PNPLA7;PLA2G6;LYPLA1;MGLL;ABHD16A;LYPLAL1;ENPP2;GDPD3;LYPLA2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5452151391872493,1.3737231158216952,0.12909441233140656,0.6021817056084696,1.0,14/32,20.94%,KCNG1;KCNQ4;KCNE4;KCNQ5;KCNE5;KCNA4;KCNQ3;KCNC4;KCNG2;KCNS3;KCNH1;KCNC2;KCNC1;KCNB2
prerank,sodium channel activity (GO:0005272),0.5290751009634472,1.3732744920302618,0.1480804387568556,0.5956994334890557,1.0,14/37,13.64%,CACNA1H;GRIK1;SCN2A;SCN5A;ASIC2;HCN2;SCN8A;HCN3;SCN9A;PKD2;ASIC3;GRIK5;GRIK2;SCN1A
prerank,voltage-gated ion channel activity (GO:0005244),0.6264473615412656,1.3726704391591484,0.1574468085106383,0.5896688778054103,1.0,5/14,9.02%,CACNA1H;KCND2;GPR89A;GPR89B;PKD2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.6127441336863876,-1.371336265998846,0.11819887429643527,0.4887741833865622,1.0,5/11,15.98%,CASP12;CFLAR;CASP4;CASP8;CASP6
prerank,triglyceride lipase activity (GO:0004806),0.5907666352401658,1.3706127617056054,0.15354330708661418,0.5870079020236623,1.0,3/20,6.95%,CEL;LIPH;LIPC
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6252368395287123,-1.3648451327926108,0.12159709618874773,0.5011254414696158,1.0,6/10,23.46%,CXADR;CD47;CD200;SIRPA;DSG2;DSP
prerank,syntaxin-1 binding (GO:0017075),-0.489155286488641,-1.3619068283768536,0.1111111111111111,0.5027489163173656,1.0,3/22,3.94%,DAPK1;UNC13B;LRRK2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6124080497074115,1.3612282654810515,0.17592592592592593,0.6014651077728635,1.0,7/13,10.18%,PRKAR1B;PKIA;PRKAR2B;RYR2;PRKAR2A;CSK;PRKAR1A
prerank,poly-purine tract binding (GO:0070717),0.5460447240593231,1.3547637338913723,0.15660377358490565,0.6102127022320908,1.0,10/27,13.28%,RBPMS;RBMS3;ELAVL4;HNRNPDL;DDX3X;RBMS1;KHDRBS2;PABPC4;DAZAP1;HNRNPU
prerank,GTPase inhibitor activity (GO:0005095),-0.5704221366741387,-1.3544024466797162,0.12781954887218044,0.5170125705017141,1.0,6/13,20.36%,IQGAP1;SLIT2;CPEB2;IQGAP2;RHOH;PDE6D
prerank,sequence-specific mRNA binding (GO:1990825),0.6704112317547751,1.3538794915512629,0.15502183406113537,0.6048340062083749,1.0,5/10,16.84%,RBM24;DHFR;SSB;LARP6;FMR1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.6073826054791174,1.347008473615445,0.19433198380566802,0.6134684630454531,1.0,4/15,7.50%,PIK3CD;PIK3CA;PIK3C2A;PIKFYVE
prerank,"DNA binding, bending (GO:0008301)",-0.5445044202104082,-1.344314179666182,0.13099630996309963,0.539831822801742,1.0,6/14,16.15%,FOXD1;LEF1;FOXC1;FOXL1;HHEX;HMGB2
prerank,Tat protein binding (GO:0030957),-0.6005663801691068,-1.3437994120707546,0.12884615384615383,0.5337511299225293,1.0,6/10,27.17%,MDFIC;ACTB;GABARAPL1;SMARCA4;DLL1;CTDP1
prerank,tropomyosin binding (GO:0005523),0.5926663431399503,1.3426239301364158,0.20261437908496732,0.6161972171022094,1.0,4/16,5.35%,CALD1;SMTNL2;TMOD1;TMOD3
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6391056226704976,1.3424458079239503,0.2,0.6094394389018515,1.0,3/10,5.28%,FAP;NAALAD2;DPP10
prerank,phospholipase activator activity (GO:0016004),0.6327512812203986,1.3403847712988952,0.19238900634249473,0.6071897042974534,1.0,3/10,12.52%,ARHGAP6;STX4;SRC
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.4913329587805863,1.338269860434488,0.14669051878354203,0.6047329062273956,1.0,4/55,3.11%,SLC38A11;SLC16A12;SLC16A3;SLC19A1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6133976356364774,-1.3381222065885223,0.13099630996309963,0.5433982338219814,1.0,5/10,15.98%,CASP12;CFLAR;CASP4;CASP8;CASP6
prerank,neuropeptide receptor binding (GO:0071855),0.6015881796175213,1.3350503573589423,0.19157894736842104,0.6051076256901727,1.0,2/14,3.63%,UCN2;NMU
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.6154252768893034,1.3347050970538632,0.17857142857142858,0.5990889810670043,1.0,4/12,12.24%,OPN1MW;OPN1MW3;RRH;OPN3
prerank,sialyltransferase activity (GO:0008373),-0.5072837189954142,-1.3333596729521027,0.12770137524557956,0.5495870262201488,1.0,9/20,11.77%,ST3GAL4;ST3GAL6;ST3GAL1;ST3GAL2;ST6GALNAC3;ST3GAL3;ST6GALNAC2;ST8SIA2;ST6GALNAC6
prerank,ligand-gated channel activity (GO:0022834),0.5350081059689066,1.32920240915454,0.17890772128060264,0.6050521018562696,1.0,14/29,22.14%,CHRNA3;GRIK1;GRID1;GRIA2;GRIN2B;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;GRIA4;GRID2;GRIN1;CNGB1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.41053545426580745,1.3284460252103802,0.08957415565345081,0.600296837429877,1.0,16/147,4.79%,RAPGEF5;PLCE1;ARHGEF17;DOCK10;KALRN;RAPGEF2;DENND2A;RAPGEF4;FARP1;ARHGEF6;RASGRP2;PREX2;RALGPS1;CYTH3;EPS8L1;RIN2
prerank,FMN binding (GO:0010181),-0.5755835441109663,-1.3235234309409962,0.15019011406844107,0.5702743053445306,1.0,2/11,3.16%,POR;NOS3
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3950757741361551,-1.3227178955062273,0.07294117647058823,0.5653555498212114,1.0,24/60,13.68%,EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;TEK;TGFBR2;FGFR2;EPHB4;IGF1R;ACVR1;ACVRL1;DDR1;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;RET
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5566113748328059,-1.3180353512579173,0.17100371747211895,0.5722801423324596,1.0,7/12,32.82%,ENTPD1;ENTPD5;CANT1;ENTPD2;NUDT18;ENTPD3;NUDT5
prerank,metalloexopeptidase activity (GO:0008235),0.48231650955591615,1.317935483060161,0.1614100185528757,0.6181612972659487,1.0,6/51,3.20%,ACE2;ENPEP;CPM;METAP2;MMP15;ANPEP
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.40766618357318185,-1.3173875448160124,0.10319410319410319,0.5667611317425156,1.0,20/53,22.34%,SLC7A11;SLC47A1;SLC1A3;SLC7A2;SLC6A9;SLC7A7;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC17A6;SLC25A22;SLC66A1;SLC7A1;SLC22A2;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,serine-type peptidase activity (GO:0008236),0.426952938546279,1.3167983349021724,0.1130298273155416,0.6139418183410128,1.0,6/96,3.05%,TMPRSS4;FAP;NAALAD2;TMPRSS7;RHBDD3;RHBDF1
prerank,ligand-gated ion channel activity (GO:0015276),0.5292763495889398,1.3164263387332786,0.1806083650190114,0.6084558795998413,1.0,14/30,22.14%,CHRNA3;GRIK1;GRID1;GRIA2;GRIN2B;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;GRIA4;GRID2;GRIN1;CNGB1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.62180860023496,1.313588081581118,0.18448637316561844,0.6084489245987882,1.0,4/11,16.92%,SLC5A1;SLC2A9;SLC23A2;SLC23A1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5013832407944038,1.313509497004256,0.16448598130841122,0.6023714533330521,1.0,4/38,5.05%,SERPINI1;SERPINB8;WFDC3;SERPINA10
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3964563209627262,-1.313196529045078,0.08095238095238096,0.5720634565051567,1.0,24/60,13.68%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;NRP2;EPHA7;PDGFRA;NRP1;NTRK3;TEK;FGFR2;EPHB4;IGF1R;DDR1;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;RET
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.6411808490962589,1.3111029592220846,0.2268041237113402,0.6017118631536932,1.0,3/10,7.14%,PIK3CD;PIK3CA;PIK3C2A
prerank,actin monomer binding (GO:0003785),-0.4876746274568111,-1.3085262305396872,0.1172962226640159,0.5795926847603373,1.0,7/22,13.17%,MTSS1;LIMA1;NOS3;PRKCE;TMSB4X;PFN1;TWF1
prerank,low-density lipoprotein particle binding (GO:0030169),0.5735047798595703,1.307681231676186,0.2063157894736842,0.6027964527455602,1.0,6/16,6.95%,COLEC12;SCARB1;SCARF1;LDLR;MSR1;LIPC
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4501631205249758,1.3065258203522085,0.1468189233278956,0.5992015344372817,1.0,20/74,15.47%,DGKB;PIK3CD;DGKH;DGKG;PIK3CA;ADK;CLP1;PIK3C2A;XYLB;GK;NMRK1;DGKD;COASY;CHKB;PAPSS1;FAM20A;IPMK;FCSK;DGKI;IPPK
prerank,lipoprotein particle binding (GO:0071813),0.5515008598457231,1.3062067361669223,0.1944990176817289,0.5939624755195151,1.0,6/20,6.95%,COLEC12;SCARB1;SCARF1;LDLR;MSR1;LIPC
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.2855898763403672,-1.3049281370495005,0.0,0.5835422273012127,1.0,198/831,18.12%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;AEBP1;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;CUX1;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;OSR1;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;NFATC1;LEF1;KLF2;ETV6;TAF1;THRB;MXI1;HOXA5;SKI;ZNF23;HOXA3;ZNF697;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;ZBTB8A;TFCP2;IRF9;ZBTB18;FOXL1;LHX6;RREB1;HIF1A;MKX;TWIST2;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;ENO1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;SOX18;KDM6B;MNT;USF2;ZFP69;ZNF436;JUNB;ATF1;NFIL3;NFYB;ZFP14;NFXL1;NPAS2;MAFF;SOX12;NR6A1;CC2D1A;CEBPB;KLF15
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5831869057791961,-1.2971757319270838,0.17235188509874327,0.6002823026759817,1.0,7/10,28.90%,USP15;IDE;DNAJB2;ANKRD13D;ANKRD13A;DNAJC2;LAPTM5
prerank,protein tyrosine kinase binding (GO:1990782),-0.3785329746765478,-1.2970972696156544,0.08354430379746836,0.593168582826758,1.0,10/71,5.09%,EPHA4;CDH5;PTPN14;TJP2;DOCK4;NEDD9;BMPR2;ANGPT1;ACVR1;GAS6
prerank,iron ion binding (GO:0005506),-0.40728266130433544,-1.293827608600186,0.09977324263038549,0.5962371993225973,1.0,25/48,35.97%,KDM7A;AOX1;AGMO;EGLN2;EGLN3;FTL;KDM3A;DNAJC24;FTO;ISCA2;TYW5;FTH1;DOHH;TET2;EGLN1;CYP2R1;CDO1;TET1;HIF1AN;ACP5;RIOX1;JMJD6;HAAO;ALOX5;PHYH
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.569566629953721,-1.2935670836836939,0.16988416988416988,0.5898709245927884,1.0,5/11,25.14%,LEF1;SRRM2;GATA2;MBD2;ZXDC
prerank,phospholipase binding (GO:0043274),0.5862217773129725,1.2883309066548572,0.2145922746781116,0.6276041515775613,1.0,4/13,12.52%,ARHGAP6;WAS;BLNK;SRC
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5705619498057488,1.2881394024248185,0.21888412017167383,0.6160355052252194,1.0,1/16,0.16%,PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5705619498057488,1.2881394024248185,0.21888412017167383,0.6160355052252194,1.0,1/16,0.16%,PTPRK
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5659633693897304,-1.2866633552344318,0.16796875,0.6041527976251141,1.0,5/11,16.69%,ATP10A;ABCA3;ABCA4;ATP8A1;ATP11A
prerank,lipase activator activity (GO:0060229),0.6073153737374,1.2857999689280517,0.227765726681128,0.615596307802636,1.0,1/10,1.07%,ARHGAP6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6153711187690881,1.2852376062350912,0.23194748358862144,0.6109498556237954,1.0,3/10,9.60%,APOBEC1;ADARB2;DCTD
prerank,SH3 domain binding (GO:0017124),0.44857611249127277,1.2846898446453807,0.1592356687898089,0.6063371664431882,1.0,8/62,3.65%,SGIP1;AFAP1L2;VASP;WAS;PTPN22;WIPF1;NCF1;ABI2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.46261567712052615,-1.2844583495297348,0.130859375,0.6039303928721148,1.0,10/26,9.26%,SLC6A13;SLC16A2;SLC6A6;SLC6A12;ABCG2;SLC16A1;SLC16A6;SLC16A11;SLC6A1;SLC5A6
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5646698576996358,-1.2831406100950775,0.16962524654832348,0.6009112522663724,1.0,5/11,18.67%,SGMS1;SGMS2;PTDSS2;PIGN;PTDSS1
prerank,metallopeptidase activity (GO:0008237),-0.34828217254137356,-1.2831065489345492,0.069164265129683,0.59416701994323,1.0,32/113,16.09%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;PAPPA;ADAMTS9;ADAMTS5;ADAM9;ADAM10;ACE;ADAMTS1;ADAMTS15;ADAMTSL1;RNPEP;ERAP1;LNPEP;ADAMTSL4;MMP14;ADAM15;IDE;MMP19;ADAMTS14;ADAMTS3;SPG7;MPND;ADAM33;MMP2;AFG3L2;ADAMTSL5
prerank,G protein-coupled receptor binding (GO:0001664),-0.34350510842487636,-1.2822667283320666,0.08064516129032258,0.5898488093665127,1.0,40/132,22.31%,WNT4;WNT6;LRP6;WNT9A;RNF43;SDCBP;CXCL12;ARRB1;PDCD6IP;ACE;WNT5A;ITGB4;GNAS;TULP3;FZD7;GNA14;ZNRF3;MYOC;PTCH1;GRK2;CCL25;WNT5B;S1PR1;CCDC88C;WNT16;SFRP1;REEP1;HOMER1;GNA13;HOMER3;WNT11;FZD1;PPY;AGTR1;TAFA5;NTS;BAMBI;GNAI1;REEP2;CCL19
prerank,steroid hydroxylase activity (GO:0008395),0.5505602536652282,1.2805387565206579,0.20798319327731093,0.6096728548421683,1.0,1/16,0.61%,CYP7B1
prerank,CARD domain binding (GO:0050700),-0.5117260387490237,-1.2804393431276582,0.143646408839779,0.5890297899182038,1.0,6/14,10.94%,NOD1;CASP4;CARD14;IRGM;CARD10;MAVS
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.5340168068227938,-1.280005666875725,0.16666666666666666,0.5837565225352301,1.0,6/13,19.48%,SLC7A2;SLC7A7;SLC38A5;SLC66A1;SLC7A1;SLC25A29
prerank,sequence-specific DNA binding (GO:0043565),-0.28464018027993937,-1.2781924800542035,0.0,0.5825607328491909,1.0,130/590,18.12%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;SMAD3;FLI1;NFAT5;FOXP1;HDAC4;GLI2;CUX1;NFIX;CREB5;HOXB6;ELF2;FOXO1;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;FOXD1;TBX15;KLF4;NR3C2;TCF4;TCF7L2;FOXC2;NFATC1;LEF1;KLF2;TAF1;THRB;HOXA5;ZNF23;ARNT2;RARG;CREM;GLIS2;SOX13;BHLHE40;TEAD1;SIX1;HLF;KDM5B;TET3;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;BPTF;NR2C2;KLF10;TBX1;SMG6;TFCP2;IRF9;ZBTB18;VSX1;FOXL1;LHX6;UPF3A;HIF1A;FOXK1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;PRDM5;ZKSCAN3;TGIF1;ESRRG;KLF12;GATA2;CEBPG;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;PPARA;MEF2A;USF1;GATA6;ZGPAT;CLOCK;MEIS2;RFX2;HSF2;CREB3L1;SLTM;POU2F1;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;SNAI1;CREB3;JUND;SREBF1;HHEX;SOX18;CENPB;USF2;JUNB;MYRF;SMG5;FBXL19;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;CEBPB;KLF15
prerank,MAP kinase activity (GO:0004707),-0.523625518173817,-1.275793174501552,0.16792452830188678,0.5832026259596934,1.0,4/14,14.53%,MAPK4;MAPK14;MAPK6;MAPK3
prerank,metallocarboxypeptidase activity (GO:0004181),0.5200789304191449,1.274258942193035,0.2,0.6170121136984509,1.0,2/26,0.96%,ACE2;CPM
prerank,cholesterol binding (GO:0015485),-0.4005053112348261,-1.2739411990659608,0.11699779249448124,0.5819817972044811,1.0,15/47,14.82%,ABCA1;OSBPL8;CAV1;APOD;OSBPL10;GRAMD1C;GRAMD1A;PROM1;SIDT1;NPC2;OSBPL1A;PTCH1;STARD3;STARD4;OSBP2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5658421380436885,-1.2724552114619954,0.175,0.5795260305813008,1.0,3/10,10.03%,MECOM;PRDM16;EHMT1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5581381149076378,-1.2676723774349468,0.16455696202531644,0.5871014886767181,1.0,4/11,17.56%,SASH1;DAB2IP;PPEF2;ROR2
prerank,adenylate cyclase binding (GO:0008179),0.6105342990183821,1.2650164980325225,0.2478813559322034,0.6321530875301848,1.0,4/10,8.29%,CAP2;AKAP6;CAP1;AKAP12
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.5957106630843578,1.2647704990977466,0.2542372881355932,0.6268332873363026,1.0,6/12,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABRB2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.2803109291556638,-1.2617814015672544,0.009345794392523364,0.597689314750511,1.0,119/597,15.54%,NFIB;BNC2;PBX1;PKNOX2;MAF;SMAD3;FLI1;SMARCA2;SMAD6;NFAT5;FOXP1;HDAC4;GLI2;CUX1;TBL1XR1;NFIX;CREB5;HOXB6;ELF2;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;TBX15;KLF4;NR3C2;TCF4;TCF7L2;FOXC2;NFATC1;LEF1;KLF2;THRB;HOXA5;CREB3L2;ZNF23;ARNT2;AR;BRD7;RARG;CREM;YAP1;GLIS2;SOX13;BHLHE40;CENPC;IRF1;TEAD1;SIX1;HLF;KDM5B;PRDM16;FOXC1;IRF2;GLIS1;CHD3;HIVEP1;STAT3;HINFP;NR2C2;KLF10;TBX1;TFCP2;IRF9;ZBTB18;VSX1;LHX6;FOXK1;CARM1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;PRDM5;TGIF1;ESRRG;KLF12;GATA2;CEBPG;NFYC;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;RELA;USF1;GATA6;CLOCK;ZW10;MEIS2;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;CREB3L1;HOXC4;HOXB5;HOXB7;SOX7;BEND3;SNAI1;CREB3;JUND;SREBF1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.3924399486172529,-1.2592826318286479,0.13194444444444445,0.599160656263095,1.0,8/49,3.96%,ANXA3;PLA2G4A;CPNE8;ANXA4;ESYT2;ANXA5;ANXA2;ANXA1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.39673865988641044,-1.2586881972752564,0.13808463251670378,0.5948963219394892,1.0,17/51,16.02%,SLCO2B1;SLC16A2;MCU;SLCO2A1;ANKH;SLCO1C1;SLC20A2;SLC22A6;TMEM241;SLC22A4;SLC7A5;SLC5A6;CLCN3;SLC5A5;MFSD2A;SLC35D2;SLC35E4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5714639956730309,1.2548898148636882,0.2459016393442623,0.6423177777551936,1.0,1/15,0.22%,NDST3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.41653695226915466,1.2523437487103175,0.16640746500777606,0.6424059708483455,1.0,20/100,14.04%,MYO1B;ADAP2;FERMT2;ARAP2;CYTH3;SNX20;OGT;RPH3A;TTPAL;MYO10;GAP43;PLEKHA5;HIP1;PLA2G4E;PIRT;ARHGAP9;ZFYVE28;ANKFY1;RLBP1;ATG2B
prerank,ATP binding (GO:0005524),0.35788276538436287,1.248439701945755,0.12026143790849673,0.6453908798196939,1.0,45/266,12.09%,MYO1B;KCNJ8;MAP3K20;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;AGAP2;AKT3;RPS6KA4;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;MINK1;CLP1;SYN2;RRM1;SYN1;SIK1;MCM6;LIG4;PAPOLA;HSPA14;PEX1;STK3;MARK2;MAP4K4;GCK;MAP4K1;NEK6;ABCF3;DARS2;DYRK3;BRSK1;LATS2;SRR;NLK;PFKM
prerank,transcription coactivator binding (GO:0001223),-0.4730063449176054,-1.2475458025918564,0.19760479041916168,0.6212933608581855,1.0,10/20,15.49%,SMAD3;VGLL4;ESR1;THRB;AR;PGR;AHR;RELA;CDK9;RPL23
prerank,ADP binding (GO:0043531),-0.44836762281699183,-1.2427112831413927,0.16363636363636364,0.6296017960258075,1.0,7/25,11.52%,PRKAG2;MYO18A;ME1;MYH10;GCLC;MYO9B;ERN1
prerank,ubiquitin-specific protease binding (GO:1990381),0.5267388448209769,1.2418623631139682,0.2463768115942029,0.6547779738823034,1.0,3/19,6.51%,PTEN;DERL3;SART3
prerank,titin binding (GO:0031432),-0.5197417686395455,-1.2397663211487515,0.19193857965451055,0.6319702098408574,1.0,4/13,16.18%,ACTN2;CALM2;TRIM63;CALM1
prerank,active ion transmembrane transporter activity (GO:0022853),0.4779520186825041,1.2383187294936815,0.2290909090909091,0.6573517634631227,1.0,6/37,5.04%,SLCO3A1;COX4I2;NDUFA4L2;SLCO5A1;UQCRFS1;SLC22A8
prerank,ligand-gated cation channel activity (GO:0099094),0.41456783216686727,1.2339861460780266,0.19349593495934958,0.6607959010579155,1.0,18/75,16.32%,KCNJ8;KCNJ12;CHRNA3;GRIK1;ASIC2;GRIA2;CHRNA7;KCNJ3;GRIN2B;KCNJ6;ASIC3;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;P2RX5;GRIA4
prerank,pentosyltransferase activity (GO:0016763),0.47601986738281205,1.2318099015825843,0.22826086956521738,0.6602423846236466,1.0,2/36,0.90%,ART3;PARP8
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.3255295449243279,-1.2317964777994357,0.0729483282674772,0.6490067753941278,1.0,29/134,11.62%,ABCC4;SLC6A13;SLC13A3;SLC1A3;PDPN;SLCO2B1;SLC6A6;SLC26A7;SLCO2A1;SLC26A2;GJA1;SLCO1C1;ABCG2;SLC7A2;SLC16A1;SLC22A6;SFXN2;SLC16A11;SLC6A9;SLC7A5;SLC25A17;SLC6A1;SLC5A6;SLC25A38;SLC38A5;SLC39A8;SLC25A24;SLC3A2;SLC38A6
prerank,DNA binding (GO:0003677),-0.2711490419460304,-1.2272529848080094,0.010416666666666666,0.6566358276312841,1.0,198/694,24.60%,NFIB;TSHZ2;FOXP2;PBX1;ZNF423;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;HDAC4;DENND4A;GLI2;CUX1;FOXO1;FOXO3;APP;ZIC2;ERG;NUPR1;RARB;MEOX2;FOXD1;DNMT3A;PLAGL1;TCF4;TCF7L2;FOXC2;LEF1;KLF2;TAF1;THRB;HOXA5;DDX60;HDGFL3;SSBP2;QRICH1;RARG;CREM;SOX13;THRAP3;CENPC;PDS5B;IRF1;TEAD1;SIX1;INO80;ZNF292;HLF;KDM5B;PRDM16;FOXC1;IRF2;SSBP1;CHD3;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;RAD51B;ZNF219;TBX1;RTF1;POLR2A;RC3H2;ERCC5;TFCP2;ZBTB18;DCLRE1C;AIFM1;FOXL1;REXO4;HIF1A;PCBP2;TRIM16;NHEJ1;NR4A2;ATF6;SAMHD1;IKZF1;ZC3H12A;PRDM5;ZKSCAN3;KLF12;BRCA2;NABP1;CEBPG;PATZ1;NFYC;DNASE1L1;AHR;LRRFIP1;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;CALR;ZGPAT;RPS27;TDG;CLOCK;XRCC4;SPHK1;MEIS2;EZH1;RFX2;RPL7;DDB1;RPA1;SLTM;POU2F1;ZBTB4;RAD50;CDK9;RPS15;TAF4B;SREBF1;APLP2;XRN1;CEBPZ;HHEX;MEIS1;GTF3C2;HMGB2;SPO11;GTF3C5;CENPB;USF2;JUNB;MYRF;TSHZ1;PSIP1;HMGN1;NFYB;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;DEDD;CEBPB;PARK7;SIRT3;YAF2;MCMDC2;RFC3;PPARGC1A;E2F1;SMARCAD1;GTF3C1;CTCF;POU2F2;POLRMT;SMC1A;HP1BP3;NFATC2;RAD52;THAP1;TOP3A;CHRAC1;GLI1;FOXD2;NR5A2;DEDD2;RFC1;SP7;XBP1;DNMT1;ZMYND11;TOP2A;RAD51C;NEIL3;ZNF513;NR4A3;MCM8;LYAR;HDGFL2;SMARCA4;WBP11;RAD51;CDC45;ERCC1;CBFB;ERCC2;MSH6;SATB1;BRCA1;PAX3;RNF11;FOXL2;EGR1;RPA3;POLR2G
prerank,GDP binding (GO:0019003),0.4256571960163896,1.226564930680154,0.20811287477954143,0.6662137674078267,1.0,8/63,7.86%,RASL12;RERG;RAB8B;RIT2;RAB3B;RAP1A;HRAS;RAB28
prerank,chemokine receptor activity (GO:0004950),0.5055447854636523,1.2226682435098506,0.24950884086444008,0.6692612738820971,1.0,5/24,8.20%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4176621587625316,1.222066732586202,0.22258064516129034,0.6650524541797591,1.0,4/72,2.26%,MYO1B;ADAP2;MARK1;LDLRAP1
prerank,thioesterase binding (GO:0031996),0.5750262183048886,1.220790021242058,0.2733485193621868,0.6623094176397669,1.0,8/11,26.97%,TRAF5;TRAF3;TRAF6;TRAF2;ARF6;TRAF1;HAUS7;CDC42
prerank,exoribonuclease activity (GO:0004532),-0.5243459138204676,-1.2200093895636042,0.22090729783037474,0.6718714617487058,1.0,4/12,23.74%,CNOT7;ZC3H12A;EXOSC5;EXOSC7
prerank,phospholipase activity (GO:0004620),0.4279814998969544,1.2192462294546824,0.20862068965517241,0.660188245875498,1.0,7/67,7.18%,PLCL1;PLCE1;PLD6;LIPH;LIPC;ABHD3;PLAAT1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.33497389154158697,1.2187216296101393,0.12832929782082325,0.6560169963060105,1.0,59/431,10.73%,MYO1B;RASL12;REM1;KCNJ8;RERG;MAP3K20;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;RND3;AGAP2;RRAD;AKT3;RPS6KA4;NOA1;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;RAC3;MINK1;CLP1;RIT2;TUBA8;SYN2;ARL4C;RRM1;SYN1;SIK1;MCM6;LIG4;RAP1A;HRAS;PAPOLA;HSPA14;TUBB2B;RAB28;PEX1;STK3;RAB38;MARK2;MAP4K4;RNF112;GCK;MAP4K1;NEK6;ABCF3;DARS2;DYRK3;TUBG2;ARL5C;BRSK1
prerank,sodium:proton antiporter activity (GO:0015385),-0.5321044791432037,-1.2173962155062739,0.23076923076923078,0.6734817744070344,1.0,3/11,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,neuropeptide receptor activity (GO:0008188),0.5044600604081176,1.2170014433433414,0.26958105646630237,0.6545481290153115,1.0,10/29,18.50%,TACR2;SORCS1;TACR1;NPSR1;GPR37;NPY1R;NTSR1;TACR3;NPY2R;SSTR2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5612149918922564,1.2165605695676085,0.2651685393258427,0.6502549317289547,1.0,4/12,10.60%,PIK3R1;SH2B3;IRS1;BLNK
prerank,phosphatidylinositol binding (GO:0035091),0.4072609264015754,1.216392077716957,0.1890625,0.6455149892755542,1.0,12/91,6.72%,PITPNC1;PIGU;SCARB1;ITPR2;NCF1;EPB41;MREG;ITPR1;PITPNM2;RPH3A;WDFY3;APPL1
prerank,metalloaminopeptidase activity (GO:0070006),0.536368386677476,1.2156710435016664,0.2597402597402597,0.6419585348969563,1.0,3/16,3.20%,ENPEP;MMP15;ANPEP
prerank,monocarboxylic acid binding (GO:0033293),-0.4675880662558486,-1.2153778348065283,0.2277992277992278,0.6732592867953403,1.0,5/18,26.97%,CYP26B1;PSAP;RARA;RXRA;PYGL
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.513893666563714,1.214848567427359,0.2729124236252546,0.638662706916099,1.0,4/22,3.59%,RBMS3;CPEB1;RBM24;ELAVL4
prerank,cadherin binding (GO:0045296),0.3473572486728854,1.2147976393651654,0.14949748743718594,0.6338518703111727,1.0,34/315,7.13%,NOTCH3;TRPC4;MYO1B;CALD1;COBLL1;CDH2;CDH4;CEMIP2;VCL;PHLDB2;MPRIP;ARHGAP1;VASP;TNKS1BP1;MYH9;CD46;EFHD2;CDC42EP1;SPTBN1;CTNNA3;EPS8L1;TMOD3;ITGB1;CDH8;ANK3;CHMP2B;DDX3X;PDLIM1;CDH22;YWHAZ;CDH19;CDH20;CDH7;WASF2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.4337831282038016,-1.2129343914873838,0.21485943775100402,0.674404959388555,1.0,6/27,11.28%,SLC9A2;SLC41A1;SLC8A3;SLC9B2;SLC9A9;SLC3A2
prerank,5'-nucleotidase activity (GO:0008253),-0.5040051253810507,-1.2102280305563227,0.222011385199241,0.67590881558473,1.0,9/13,40.11%,NT5E;NT5DC3;NT5C1A;NT5C2;NT5C;ACP3;NT5C3B;NT5DC2;NT5C3A
prerank,transmitter-gated ion channel activity (GO:0022824),0.4889365279747328,1.2096775525780314,0.2704761904761905,0.639788462838257,1.0,12/29,18.54%,GRIK1;GABRG2;GRID1;GRIA2;GABRA2;GABRA5;GABRA4;GRIK5;GRIK2;GABRB3;GRIA4;GRID2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.3035942986186307,-1.2084260971542649,0.10545454545454545,0.675333113268565,1.0,49/188,18.15%,BNC2;PBX1;SMAD3;FLI1;SMARCA2;SMAD6;HDAC4;TBL1XR1;FOXO3;KLF4;TCF7L2;FOXC2;CREB3L2;AR;BRD7;YAP1;GLIS2;SOX13;IRF1;SIX1;PRDM16;FOXC1;CHD3;STAT3;HINFP;VSX1;FOXK1;CARM1;ATF6;PRDM5;NFYC;AHR;RELA;GATA6;HDAC5;ZNF568;TAL1;SOX17;CREB3L1;SOX7;JUND;HHEX;HMGB2;SOX18;NFYB;SOX12;CEBPB;KLF15;BASP1
prerank,actin binding (GO:0003779),0.3698124849871237,1.207636777908957,0.17280453257790368,0.6389722726062186,1.0,30/170,8.41%,EPS8;CALD1;CAP2;UTRN;DMD;SYNE1;PTK2;VCL;MYH9;FERMT2;SPEF1;SSH2;CORO7;NCALD;ADCY8;TMOD1;CORO2B;FMN2;EPS8L1;ACTN4;SPTB;ITGB1;RUSC1;SNCA;PDLIM1;SMTN;CAP1;MYL3;MYO6;CORO1A
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.547618416057772,-1.206849331117814,0.25411334552102377,0.6738798185511792,1.0,6/10,28.90%,IDE;PML;DNAJB2;ANKRD13D;ANKRD13A;LAPTM5
prerank,serine-type endopeptidase activity (GO:0004252),0.4008073151709481,1.20600806895583,0.20095693779904306,0.6373924803142705,1.0,4/80,3.05%,TMPRSS4;FAP;RHBDD3;RHBDF1
prerank,BMP binding (GO:0036122),-0.5264763276329203,-1.2037586681953691,0.24721189591078066,0.6768999751170421,1.0,3/11,6.39%,BMPR2;GREM2;NBL1
prerank,histone acetyltransferase activity (GO:0004402),-0.4143595132971376,-1.2036050821882716,0.2334047109207709,0.6713786610407748,1.0,15/30,25.98%,KAT6B;KAT2B;TAF1;KAT14;ARRB1;BAZ1A;TADA2A;BRCA2;CLOCK;NAA40;USP22;MCM3AP;HAT1;ATF2;EPC1
prerank,aminopeptidase activity (GO:0004177),0.4942619774949455,1.2028688915943497,0.27236580516898606,0.6396231093762329,1.0,4/26,3.20%,ENPEP;METAP2;MMP15;ANPEP
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5145086994230549,1.2000275847525081,0.2563106796116505,0.6405513986225169,1.0,3/17,5.14%,PITPNC1;PITPNM2;ATP8B2
prerank,chloride channel regulator activity (GO:0017081),-0.4926708595042083,-1.1944219721634703,0.27169811320754716,0.6920687875548347,1.0,4/14,10.34%,WNK4;STX7;WNK1;STX1A
prerank,fibroblast growth factor binding (GO:0017134),-0.4501878024244593,-1.1939358695255273,0.25346534653465347,0.6875253437534561,1.0,7/21,15.24%,FGFR2;THBS1;KL;RPS19;ITGB3;FGFR4;GLG1
prerank,protein kinase C activity (GO:0004697),-0.48679909108637204,-1.1911904446366433,0.2643253234750462,0.6895288508840283,1.0,6/14,10.98%,PRKCH;PRKCE;PRKCZ;PRKCB;PRKCD;PRKCG
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5074205290025554,-1.1911093785272984,0.24404761904761904,0.683898134731253,1.0,5/12,8.57%,IGF1;SOCS2;IGF2;ARRB1;GNAS
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40810358590530027,1.18797661155716,0.23168654173764908,0.6618968864455893,1.0,6/71,2.78%,PTPRK;PTEN;PALD1;PTPN9;TNS2;PTPN22
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.38102580503010297,-1.1876770243708383,0.2160919540229885,0.6877935423647589,1.0,10/42,7.45%,PDLIM5;BAIAP2L1;STXBP6;ANXA2;BSG;BAIAP2;ANXA1;PALLD;CNN3;CD47
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5598427886805215,1.187632669626708,0.29116465863453816,0.657839475494931,1.0,3/12,7.14%,PIK3CD;PIK3CA;PIK3C2A
prerank,calcium ion binding (GO:0005509),0.3395587481373177,1.1868860661853686,0.1523687580025608,0.6545337499906813,1.0,60/323,11.72%,ASPN;CASQ2;ADGRL3;CDH2;CDH4;RAPGEF2;DYSF;AIF1L;RASGRP2;CEMIP2;SLIT1;SLIT3;ITPR2;RASGRP3;CIB3;EFHD2;NRXN1;PVALB;STIM2;ITPR1;AGRN;PPP3CA;DNER;PITPNM2;ASTN2;SPARCL1;SLC25A13;RPH3A;CDH8;SNCA;RYR2;ATP2A2;CDH22;CDH19;CDH20;CDH7;AOAH;PADI2;STIM1;SYT1;RYR3;LETM1;PKD2;BNIP2;HPCA;CDH10;CDH18;SPOCK1;BAIAP3;ASAH2;PLA2G4E;KCNIP1;PGS1;CASQ1;BRAF;CHP2;MICU3;SYT2;KCNIP4;SRR
prerank,lipase activity (GO:0016298),0.44194678661327785,1.1857975639917795,0.26148409893992935,0.6520452169166833,1.0,5/43,7.16%,CEL;PLA1A;LIPH;LIPC;ABHD3
prerank,peptide hormone receptor binding (GO:0051428),0.5583265796252755,1.1834206662779767,0.3138075313807531,0.6524999882736094,1.0,2/11,7.59%,UCN2;CCK
prerank,histone deacetylase activity (GO:0004407),-0.4565848772300929,-1.1808964947326492,0.2407766990291262,0.7016250670283227,1.0,8/19,18.47%,HDAC4;HDAC8;HDAC9;HDAC1;HDAC5;SIRT7;SIRT2;SIRT3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5922259416408664,1.1797469027136285,0.3108695652173913,0.6553587281376143,1.0,3/10,9.84%,NCF2;NCF1;NOX3
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5449759828559214,1.1795041187391433,0.2857142857142857,0.6513235527382464,1.0,3/11,14.68%,CHRNA3;CHRNA7;CHRNB2
prerank,phospholipid transfer activity (GO:0120014),0.4925736219100817,1.1793858938726067,0.2835538752362949,0.6470468974381681,1.0,3/21,6.57%,PITPNC1;PITPNM2;PRELID3A
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.3991125152946543,-1.1772023608398894,0.21645021645021645,0.7005299072285336,1.0,16/34,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.3991125152946543,-1.1772023608398894,0.21645021645021645,0.7005299072285336,1.0,16/34,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,symporter activity (GO:0015293),-0.5249490981722345,-1.176813063336024,0.2859848484848485,0.6958216271127853,1.0,3/10,13.16%,SLC5A6;SLC5A5;MFSD2A
prerank,double-stranded DNA binding (GO:0003690),-0.26714937918533577,-1.1766379547560804,0.04032258064516129,0.6906470647999877,1.0,99/531,15.54%,NFIB;PBX1;PKNOX2;MAF;FLI1;EGFR;NFAT5;FOXP1;GLI2;CUX1;NFIX;CREB5;HOXB6;ELF2;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;TBX15;KLF4;NR3C2;TCF4;FOXC2;NFATC1;LEF1;KLF2;THRB;HOXA5;ZNF23;DDX60;HDGFL3;ARNT2;RARG;CREM;GLIS2;BHLHE40;TEAD1;SIX1;HLF;KDM5B;IRF2;GLIS1;HIVEP1;STAT1;NR2C2;RAD51B;KLF10;TBX1;ERCC5;TFCP2;IRF9;ZBTB18;VSX1;LHX6;REXO4;FOXK1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;TGIF1;ESRRG;KLF12;GATA2;CEBPG;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;USF1;GATA6;TDG;CLOCK;MEIS2;RFX2;HSF2;CREB3L1;HOXC4;RAD50;HOXB5;HOXB7;SOX7;SNAI1;CREB3;JUND;SREBF1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4170862150292631,1.176189432936257,0.24707846410684475,0.6491147465527453,1.0,6/60,4.23%,PTEN;CTDSPL;PHLPP1;PPM1E;PPP3CA;LRRC40
prerank,outward rectifier potassium channel activity (GO:0015271),-0.515625547255185,-1.1758633433440995,0.2702205882352941,0.6871542547182489,1.0,3/11,10.56%,KCNK2;KCNQ1;KCNT1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4423941075046313,1.174965681927243,0.26846846846846845,0.6470995406651543,1.0,2/47,1.78%,SLC38A11;SLC1A5
prerank,kinesin binding (GO:0019894),0.4859022722414641,1.1746453751247898,0.2949907235621521,0.6432703937083663,1.0,6/27,9.93%,CLSTN1;TOR1B;AP1G1;AP1AR;SNCA;NEK6
prerank,NADP binding (GO:0050661),-0.400595652868416,-1.1738027153185002,0.25389755011135856,0.6880075201828436,1.0,13/32,27.29%,GMDS;LBR;NOS3;DPYD;ME1;NNT;PGD;NOS1;NOX1;DECR1;ME3;GRHPR;MTRR
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.3457635328443292,-1.1729066464694178,0.22081218274111675,0.6848686747403893,1.0,11/70,11.41%,GXYLT2;EXT1;LARGE1;B4GALT1;CSGALNACT1;CHSY1;HEXA;HEXB;B3GALNT1;POGLUT1;POGLUT2
prerank,manganese ion binding (GO:0030145),-0.3737803643522243,-1.1722188921294816,0.2364066193853428,0.6814037297297141,1.0,21/48,30.13%,LARGE1;B4GALT1;XPNPEP1;MPPED2;PPM1M;ME1;MGAT1;MTPAP;MGAT2;ADCY2;FAM20C;NUDT16;MPPE1;HMGCL;XXYLT1;SOD2;ABL1;ATP13A2;ENDOU;POMGNT1;WRN
prerank,pyrophosphatase activity (GO:0016462),-0.36977381466172704,-1.1718452024496815,0.21541950113378686,0.6771566526200833,1.0,27/50,33.35%,ENTPD1;ENPP1;ENPP3;NUDT4;ALPL;NUDT3;PLPP1;ENTPD5;LHPP;ENTPD2;DOLPP1;NUDT6;PLPP4;CILP;PPA1;NUDT16;NUDT1;CILP2;TRPM2;BNIPL;DXO;ENTPD3;NUDT5;NUDT9;NUDT10;DHX29;FITM2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5258546863466131,-1.1711695455067854,0.286527514231499,0.6739120153467054,1.0,1/10,0.92%,KDM7A
prerank,Wnt-activated receptor activity (GO:0042813),0.5198159237879496,1.1666054204891376,0.3048016701461378,0.6549369630197295,1.0,4/15,4.94%,ROR1;FZD6;RYK;TSPAN12
prerank,ATPase binding (GO:0051117),-0.33879522706058074,-1.165074270175672,0.20987654320987653,0.6855059960130554,1.0,19/71,11.81%,ABCA1;EGFR;ATP1B3;TMTC4;SNTA1;PTPN3;CAV1;SLC2A13;ESR1;EZR;ATP6V0A4;AR;PGR;ATP6V1G1;TOR1AIP1;CHMP4A;NOP58;ATP6V0A1;TCIRG1
prerank,transcription cis-regulatory region binding (GO:0000976),-0.268506508367254,-1.1616809802200385,0.05945945945945946,0.6898439542361811,1.0,91/406,18.15%,BNC2;PBX1;FOXN3;AEBP1;SMAD3;FLI1;SMARCA2;SMAD6;FOXP1;HDAC4;CUX1;TBL1XR1;OSR1;FOXO3;NR3C1;MLXIP;KLF4;PLAGL1;TCF7L2;FOXC2;TFDP2;LEF1;ETV6;MXI1;CREB3L2;AR;BRD7;CREM;YAP1;HIF3A;GLIS2;SOX13;IRF1;TEAD1;SIX1;PRDM16;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;KLF10;ZBTB8A;TFCP2;VSX1;LHX6;RREB1;HIF1A;TWIST2;FOXK1;CARM1;ATF6;FOSL2;PRDM5;NFYC;GLI3;ELK3;AHR;HDAC1;RELA;MEF2A;GATA6;HDAC5;ZNF568;TAL1;SOX17;HSF2;CREB3L1;ENO1;ZBTB4;SOX7;SNAI1;CREB3;JUND;SREBF1;HHEX;HMGB2;SOX18;MNT;ZFP69;ZNF436;ATF1;NFIL3;NFYB;NFXL1;SOX12;CEBPB;KLF15;PARK7;BASP1
prerank,GABA-A receptor activity (GO:0004890),0.5095335989314815,1.1607619318521514,0.3347457627118644,0.6623200088858572,1.0,6/18,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABRB2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5431133234912855,1.160624214214673,0.308300395256917,0.65812905864934,1.0,2/11,1.24%,MAP3K20;MAP3K5
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3832802190895109,1.1580724674115066,0.24804992199687986,0.6588222117640191,1.0,4/91,2.26%,MYO1B;ADAP2;MARK1;LDLRAP1
prerank,disordered domain specific binding (GO:0097718),-0.42271343685874596,-1.1554731028197849,0.26796116504854367,0.702137169609614,1.0,9/23,21.23%,FN1;CALM2;MDM2;HSP90AB1;CALM1;PPIL1;NUMA1;TEAD2;DFFB
prerank,tubulin binding (GO:0015631),0.32872200476141794,1.155256820860384,0.19551681195516812,0.6602710760435144,1.0,42/295,11.88%,DLEC1;SGIP1;STARD9;MAP2;MTCL1;RMDN1;SPEF1;MID2;NCALD;SVBP;FGF13;IFT81;NAV3;GAS8;CLASP2;MAPRE2;ARL4C;SNCA;DDX3X;TPPP;APPL1;KIF26B;HOOK3;TTLL11;FAM161A;MAP4K4;CLIP2;TTLL12;NUSAP1;KIF3A;UXT;BRSK1;ARHGEF7;TOGARAM2;MACO1;TPGS1;CCDC66;PAK1;KIF20A;KIF5C;APC;KIF3C
prerank,ionotropic glutamate receptor activity (GO:0004970),0.49990764834661067,1.153076515461281,0.3106212424849699,0.6602932671509569,1.0,8/17,16.32%,GRIK1;GRIA2;GRIN2B;GRIK5;GRIK2;GRIN2A;GRIA1;GRIA4
prerank,NAD+ binding (GO:0070403),-0.4981464142298163,-1.1518948947803218,0.2926829268292683,0.706603594731659,1.0,4/12,18.47%,CRYL1;PARP9;SIRT2;SIRT3
prerank,cation:chloride symporter activity (GO:0015377),0.5512488298525696,1.1518547849606264,0.31965442764578833,0.6584093716944801,1.0,4/10,13.22%,SLC12A2;SLC12A6;SLC12A5;SLC12A4
prerank,proton transmembrane transporter activity (GO:0015078),0.43070361574797345,1.1516753893976668,0.2867132867132867,0.6545274243317344,1.0,6/39,11.86%,COX4I2;NDUFA4L2;UQCRFS1;ATP6V1B2;COX4I1;COX5A
prerank,guanyl ribonucleotide binding (GO:0032561),0.3421341230653238,1.150214763396254,0.23895027624309392,0.6528699470668211,1.0,22/196,8.86%,RASL12;REM1;RERG;RAPGEF2;PDE5A;RND3;AGAP2;RRAD;RAB8B;SLC19A1;NOA1;RAC3;RIT2;TUBA8;ARL4C;RAB3B;RAP1A;HRAS;TUBB2B;RAB28;RAB38;RNF112
prerank,receptor ligand activity (GO:0048018),-0.2806518891801224,-1.150180743924141,0.11923076923076924,0.7058386643477419,1.0,29/245,7.70%,BMP6;IGF1;EPHA7;WNT4;SEMA3D;BMP7;SEMA6A;TGFA;SEMA3C;IL15;WNT6;DPP4;BMP4;SEMA7A;CSF1;WNT9A;VEGFD;TNFRSF11B;VEGFC;IL16;IGF2;GAS6;FGF1;GREM2;WNT5A;CCL15;NBL1;SEMA3E;OSGIN2
prerank,myosin binding (GO:0017022),0.41957567625742764,1.1499626872284796,0.2920962199312715,0.649237131148392,1.0,12/55,12.65%,CALD1;DMD;RAB39B;RAB3B;ARFGEF1;KIRREL1;CORO1A;NKD2;TRAK1;STXBP5L;TRAK2;NPHS1
prerank,syntaxin binding (GO:0019905),-0.34900247724903266,-1.1499011942982604,0.22982885085574573,0.7014266911878148,1.0,19/61,21.45%,DAPK1;UNC13B;ABCA1;RAB11A;LRRK2;STX7;SNAP23;STXBP4;STX6;SCFD2;SNAP47;NAPA;BLOC1S6;SYT9;VPS52;PTPN2;TMED9;UNC13C;VAMP8
prerank,MAP kinase phosphatase activity (GO:0033549),-0.4992998777986008,-1.1493442627771657,0.3121495327102804,0.6977342006769899,1.0,6/12,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.47580894842375765,-1.146553682093257,0.30303030303030304,0.7004778012264022,1.0,4/14,6.06%,TIMP3;RECK;TIMP2;SPOCK2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.482419573186265,1.1452864105545755,0.3165618448637317,0.6543036485426597,1.0,7/20,13.00%,USP25;SENP5;OTUD5;DESI2;SENP1;OTUB1;USP50
prerank,endopeptidase activity (GO:0004175),-0.2766163302131976,-1.142831388666238,0.13533834586466165,0.7052859389783857,1.0,57/257,16.09%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;CTSH;PCSK5;ADAMTS9;F3;HTRA3;ADAMTS5;DPP4;USP47;ADAM9;CTSC;USP46;ADAM10;CASP4;ACE;ADAMTS1;USP12;ADAMTS15;ADAMTSL1;USP8;KLK2;USP15;ADAMTSL4;PIK3IP1;USP18;MMP14;CTSB;USP34;CASP8;IDE;MMP19;USP35;USP11;USP5;ADAMTS14;RHBDF2;CTSS;ADAMTS3;USP49;PSMB4;PREP;SPG7;RHBDL3;SFRP1;PSMB1;ADAM33;MMP2;PDIA3;CASP6;AFG3L2;ADAMTSL5
prerank,cysteine-type peptidase activity (GO:0008234),-0.33870547586515587,-1.1403368303196861,0.24120603015075376,0.7070970200652247,1.0,21/73,15.98%,CTSH;USP47;CAPN2;CTSC;USP46;CASP4;USP12;USP8;USP15;USP18;CTSB;USP34;CASP8;USP35;USP11;USP5;CTSS;USP49;SFRP1;PDIA3;CASP6
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.4289168979128028,-1.1389079229690384,0.29218106995884774,0.7060888203108132,1.0,4/20,7.97%,TJP2;DLG1;MAGI3;CMPK1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.5206534624163557,-1.1371875975676111,0.3088512241054614,0.7007041604513357,1.0,6/10,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.5206534624163557,-1.1371875975676111,0.3088512241054614,0.7007041604513357,1.0,6/10,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,endopeptidase inhibitor activity (GO:0004866),0.37571109363204075,1.136448752988889,0.2822966507177033,0.6681200282454606,1.0,13/82,11.21%,SERPINI1;SERPINB8;COL4A3;ROCK1;WFDC3;SERPINA10;PSMF1;BIN1;BIRC6;SPOCK3;SERPINA2;SPOCK1;PTTG1
prerank,potassium ion antiporter activity (GO:0022821),-0.4556884892861609,-1.1350473435966892,0.30902111324376197,0.7016887801253932,1.0,3/15,6.96%,SLC24A3;SLC9A2;SLC9A9
prerank,hexosyltransferase activity (GO:0016758),-0.31180310872828687,-1.1347277638146094,0.20786516853932585,0.6977359324248494,1.0,11/101,6.90%,TMTC1;EXT1;LARGE1;B4GALT1;TMTC4;CSGALNACT1;TMTC2;A4GALT;CHSY1;HEXA;HEXB
prerank,sterol binding (GO:0032934),-0.34685080682885433,-1.1337282665048245,0.24311926605504589,0.6957672277143399,1.0,17/56,14.82%,ABCA1;OSBPL8;CAV1;APOD;OSBPL10;GRAMD1C;GRAMD1A;PROM1;SIDT1;NPC2;OSBPL9;OSBPL1A;INSIG2;PTCH1;STARD3;STARD4;OSBP2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.40439480189493754,-1.130519978554039,0.33189655172413796,0.6997561823608992,1.0,16/29,33.63%,ACER2;ACER3;CTBS;PGGHG;ADPRS;GANAB;GAA;NEU3;HEXD;MOGS;ENGASE;GLA;HPSE;HYAL3;GALC;LCT
prerank,general transcription initiation factor binding (GO:0140296),-0.40807090861597506,-1.1295073891787515,0.3235294117647059,0.697620276407094,1.0,11/25,26.26%,ESR1;TAF1;AR;AHR;RELA;YEATS2;HHEX;BRF2;PSMC2;PSMC5;TAF11
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4626357330444549,-1.1263954297497996,0.31190926275992437,0.7015284836390193,1.0,1/15,1.12%,PLA2G4A
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3865983075589178,-1.1237836110609443,0.3173277661795407,0.703741140046458,1.0,17/32,36.19%,KDM7A;TET3;EGLN2;TMLHE;EGLN3;FTO;TYW5;PHYHD1;ALKBH5;TET2;EGLN1;JMJD7;TET1;HIF1AN;RIOX1;PHYH;KDM4A
prerank,protein kinase activator activity (GO:0030295),0.394703277561917,1.1231363280413231,0.2902097902097902,0.6907891154748755,1.0,13/60,8.70%,GPRC5C;AFAP1L2;RGCC;AGAP2;NRG1;GRM5;FGF13;SPDYA;SPRY2;DDX3X;CDKN1A;STK3;MARK2
prerank,transcription coregulator binding (GO:0001221),-0.35505738954581156,-1.121952813301428,0.2655086848635236,0.7039883388014401,1.0,19/50,20.84%,SMAD3;ZBTB16;LCOR;VGLL4;ESR1;THRB;AR;LMO2;PGR;EHMT1;USP11;AHR;RELA;CDK9;RPL23;EZH2;CIT;CTCF;TEAD2
prerank,transition metal ion binding (GO:0046914),-0.2603766221903911,-1.1189013218048225,0.1134020618556701,0.7072011902805958,1.0,107/397,20.85%,SMAD3;LARGE1;KDM7A;B4GALT1;HDAC4;GLI2;MOXD1;AOX1;PAM;AGMO;PAPPA;EEA1;ENPP1;XPNPEP1;MYRIP;SHANK3;NPEPPS;MPPED2;SEC23A;SEC24D;NOS3;TIMP2;KLF4;ARHGEF2;TRIM24;SKI;ZFPM2;ATOX1;LACC1;TNFSF10;ACE;ENPP3;KDM5B;TET3;TES;SEC24A;SORD;ACER3;PPM1M;CHD3;RNPEP;ME1;ERAP1;UPB1;P2RX4;BAZ1B;DUSP12;LNPEP;MGAT1;DPP3;ZMYND8;FTL;IDE;SAMHD1;MTPAP;KDM3A;DNAJC24;NSD1;GCH1;MGAT2;ADAMTS3;RNF125;MDM2;NUDT12;CALR;RPS27;PLA2G15;ADH1A;MSRB3;ADAM33;GDA;ISCA2;TYW5;SMPDL3A;PLSCR3;NOS1;TIMM13;TRIM8;SIRT2;FBXL19;PARK7;FTH1;SIRT3;ZCCHC4;ADCY2;TIMM8B;MT3;ZFYVE1;PIAS4;CTCF;CALB1;GLO1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;FNTB;FAM20C;ZDHHC15;TIMM9;THAP1;ENPP2;PHEX
prerank,WW domain binding (GO:0050699),0.4712523042613811,1.1188067026509758,0.34104046242774566,0.69561927458985,1.0,2/26,3.17%,RAPGEF2;NDFIP2
prerank,MAP kinase kinase activity (GO:0004708),-0.4586804939002535,-1.1171581887340094,0.3320825515947467,0.7074223729319983,1.0,5/15,15.00%,LRRK2;MAP2K6;MAPK14;MAP2K5;MAPKAPK3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3398542098314184,1.1158794412719806,0.2839335180055402,0.6970671243743121,1.0,17/173,5.07%,TBX2;HEY2;HEYL;ZEB1;PRDM1;TRPS1;ZBTB34;TBX3;ZFHX3;NR2F1;ZEB2;HESX1;NKX6-3;SCRT2;PPARD;ZBTB45;SREBF2
prerank,rRNA binding (GO:0019843),-0.35305172496109616,-1.1150440900243461,0.2984749455337691,0.7086035161167599,1.0,18/42,25.15%,RPS14;CAVIN1;RPS13;RPS9;RPL12;RPL11;RPS5;MDM2;MRPS7;MRPS6;MRPS18A;RPL23;RPLP0;RCC1L;UTP23;FASTKD5;RRS1;RPS3
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.43316480032940224,1.1148768452949405,0.32806324110671936,0.6948855738817323,1.0,11/29,10.18%,PRKAR1B;SPRED1;PKIA;SPRY2;HEXIM1;PRKAR2B;CDKN1A;PRKAR2A;INCA1;INKA2;PRKAR1A
prerank,metal ion binding (GO:0046872),0.3079514351988743,1.11423899142758,0.22840236686390533,0.6920164019061922,1.0,80/477,11.79%,ASPN;CASQ2;MAP3K20;ADGRL3;CDH2;CDH4;RAPGEF2;DYSF;AIF1L;MAP3K5;RASGRP2;SNRK;CEMIP2;SLIT1;SLIT3;MARK1;ITPR2;RASGRP3;NUAK2;CIB3;EFHD2;NRXN1;PVALB;STIM2;CDC42BPA;UBA2;STK38L;ITPR1;AGRN;PPP3CA;DNER;PITPNM2;ASTN2;SPARCL1;SLC25A13;RPH3A;CDH8;SNCA;TPPP;RYR2;ATP2A2;SIK1;CDH22;CDH19;CDH20;CDH7;AOAH;PADI2;PAPOLA;MTHFD2;STIM1;STK3;SYT1;RYR3;LETM1;MARK2;PKD2;BNIP2;HPCA;NEK6;CDH10;CDH18;DYRK3;ABL2;SPOCK1;BAIAP3;BRSK1;ASAH2;PLA2G4E;KCNIP1;RPE;PGS1;CASQ1;BRAF;CHP2;MICU3;SYT2;KCNIP4;SRR;NLK
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.47009154468610836,1.1130222840211708,0.34151329243353784,0.6902963365650249,1.0,5/22,10.28%,ATP2A3;ATP2C1;ATP6V0E2;ATP2A2;ATP6V1B2
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4591293584872043,1.111686240401032,0.35812133072407043,0.6889356412575447,1.0,1/20,0.46%,SLC30A10
prerank,platelet-derived growth factor binding (GO:0048407),-0.4834993698107726,-1.1102915169693794,0.35815602836879434,0.7168302630388376,1.0,6/11,2.39%,COL1A2;COL3A1;COL1A1;PDGFRA;COL5A1;COL6A1
prerank,anion transmembrane transporter activity (GO:0008509),-0.47019464620584633,-1.1082521974270643,0.3603082851637765,0.7177166660522727,1.0,4/12,10.60%,SLCO2B1;ABCG2;SLC22A6;SLC39A8
prerank,kinase activator activity (GO:0019209),0.4243634098410969,1.1080855849755573,0.3593429158110883,0.692541609707334,1.0,5/30,4.44%,GPRC5C;RGCC;AGAP2;FGF13;SPDYA
prerank,omega peptidase activity (GO:0008242),0.3686564778612858,1.1079702580776762,0.3048973143759874,0.6886270799140918,1.0,10/89,6.64%,GGT5;GGT1;USP25;JOSD2;GGH;USP40;OTUD5;UCHL1;DESI2;PAN2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3692933379840878,-1.1075878077159305,0.2958963282937365,0.7148279507690795,1.0,12/38,20.78%,PLA2G4A;SESTD1;WIPI2;ZFYVE19;PARD3;DAB2IP;PLEKHA4;SNX21;ATG2A;ZFYVE1;SNX3;BBS5
prerank,cation transmembrane transporter activity (GO:0008324),-0.34799144625435074,-1.107268588898059,0.30612244897959184,0.711064715883463,1.0,26/48,33.35%,SLC6A6;SLC41A1;SLC7A2;SFXN2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC39A1;SLC66A1;SLC7A1;SLC22A2;SLC36A1;SLC1A1;SLC38A1;MFSD12;PKD1L3;SLC6A7;SLC36A2;SLC7A3;SLC22A3;SFXN3;MMGT1;OCA2
prerank,nucleotidyltransferase activity (GO:0016779),-0.4179274238649233,-1.1031212999941609,0.3321100917431193,0.7176723946854761,1.0,7/19,20.22%,REV1;PAPSS2;TUT4;TUT7;MTPAP;PNPT1;TENT4B
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.44772056437331065,-1.1031039238491906,0.3688969258589512,0.7131987253990257,1.0,2/15,5.65%,PLA2G4A;SESTD1
prerank,acetylcholine receptor activity (GO:0015464),0.45813601167953105,1.1025236372812346,0.35135135135135137,0.6952913069922122,1.0,6/22,18.01%,CHRNA3;CHRNA7;CHRFAM7A;CHRNB2;CHRM3;CHRM2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.45881474233047104,-1.1021735107855684,0.3503787878787879,0.7109536278431083,1.0,2/14,2.95%,SLC26A7;SLC26A2
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.46734944464948047,-1.10047134808035,0.36095764272559855,0.7110403972847295,1.0,3/12,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,endopeptidase regulator activity (GO:0061135),-0.36082203683494174,-1.0980638472769964,0.32339449541284404,0.7128532253638237,1.0,6/40,11.11%,RECK;CAST;ITIH2;SERPIND1;CST3;PSME2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.48608706965272136,1.0978063013345323,0.3481781376518219,0.7007226888873331,1.0,3/15,8.20%,CCRL2;ACKR2;CCR9
prerank,metal ion:proton antiporter activity (GO:0051139),-0.45912143014182905,-1.0977464062355098,0.36654135338345867,0.7092211232735999,1.0,3/13,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,cardiolipin binding (GO:1901612),-0.47977433507285,-1.0957923271267205,0.3680297397769517,0.7096464507056689,1.0,4/10,30.55%,GSDME;GSDMD;PLEKHN1;STOML2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.45117631506125766,1.095194244426535,0.34555984555984554,0.7019859033151288,1.0,11/26,22.02%,PABIR1;PTN;PPP1R14A;PPP1R11;SET;MGAT5;CABIN1;SAG;LMTK2;STYXL1;BOD1L1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.4907825952276932,-1.0945892015621175,0.35495495495495494,0.708640669979926,1.0,6/11,33.31%,NUDT4;NUDT3;NUDT16;NUDT1;NUDT5;NUDT10
prerank,pre-mRNA binding (GO:0036002),-0.38567140397692456,-1.0943265981319983,0.3239130434782609,0.7050804315799711,1.0,2/28,3.83%,CELF2;DDX5
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.46289489187510796,-1.0942257862637383,0.36153846153846153,0.7010995519191278,1.0,2/12,2.85%,AOX1;XDH
prerank,mRNA 5'-UTR binding (GO:0048027),-0.39333815033584424,-1.0939176880256976,0.3558282208588957,0.6977275210781034,1.0,8/24,17.93%,RPS14;RPL41;RPS13;IGF2BP2;MYH10;RPL26;LARP1;RPS7
prerank,carboxylic ester hydrolase activity (GO:0052689),0.37377977574911786,1.0927561663092384,0.32972136222910214,0.7027416108922505,1.0,11/85,10.75%,NDST3;CEL;PON2;LIPC;ABHD3;PLAAT1;AOAH;MRPL58;ACHE;GDPD1;PLA2G4E
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.4103302564637176,-1.091454397875291,0.325678496868476,0.6998575950989243,1.0,5/20,20.52%,AGPAT4;LPGAT1;PLA2G15;AGPAT2;DGAT2
prerank,protein kinase regulator activity (GO:0019887),0.3611684299655873,1.0892860703003728,0.3014586709886548,0.7054920349810773,1.0,20/95,10.76%,GPRC5C;RGCC;SPRY4;PRKAR1B;AGAP2;FGF13;SPDYA;HEXIM1;CXCL10;PRKAR2B;SNCA;TAOK3;CDKN1A;PRKAR2A;ANKRD54;CCNC;MARK2;CCNYL1;PRKAR1A;PRKRIP1
prerank,DNA polymerase binding (GO:0070182),-0.4247129041084019,-1.0881416449630719,0.379182156133829,0.7040199258823964,1.0,8/18,23.23%,SMG6;FANCI;CDK2AP1;HSP90AB1;NAT10;ACD;SMARCA4;RAD51
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.49036156276605886,1.0876594324099125,0.3788187372708758,0.7044457091573728,1.0,5/13,17.93%,GABRG2;GABRA2;GABRA5;GABRA4;GLRB
prerank,sulfotransferase activity (GO:0008146),-0.36542131322976684,-1.086671163627722,0.31666666666666665,0.7038942556745754,1.0,7/33,11.97%,UST;CHST11;HS3ST3A1;HS6ST1;SULT1A1;CHST15;HS3ST1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.42622702273519036,1.086382454966786,0.3493282149712092,0.7031284850630316,1.0,8/30,15.66%,SLC30A10;ATP7A;TTYH1;ATP7B;SLC31A1;SLC30A5;SLC39A6;SLC25A37
prerank,calcium-release channel activity (GO:0015278),0.4669414311304174,1.0851963497407089,0.3697813121272366,0.7016153337408905,1.0,6/17,12.93%,ITPR2;ITPR1;RYR2;RYR3;PKD2;RASA3
prerank,nuclear receptor coactivator activity (GO:0030374),0.3999173448419513,1.083622687321506,0.36789297658862874,0.700689555289789,1.0,16/52,9.59%,PKN1;NCOA7;ETS1;NCOA3;PPARGC1B;FGF2;TACC1;ACTN4;ELK1;MED13;RBM14;NCOA6;SS18;CCAR2;MED1;CNOT9
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.3546621792340312,-1.0831674680391061,0.3254310344827586,0.7086625163635989,1.0,12/44,19.82%,MECOM;SMYD3;SETD7;SETD1B;KMT5A;PRDM16;EHMT1;NSD1;KMT5C;EZH2;SMYD5;SETDB1
prerank,kinase activity (GO:0016301),0.35287075334483015,1.0824364647135272,0.34055727554179566,0.6990575188595471,1.0,19/109,10.63%,DGKB;PIK3CD;DGKH;DGKG;PIK3CA;STK39;ITPKB;NEK1;PIK3C2A;MTOR;MAP4K4;SEPHS2;LYN;GK;COQ8A;PRKD3;NMRK1;DGKD;COASY
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4815147392356382,-1.0798955585804837,0.384180790960452,0.712916188913164,1.0,3/10,11.28%,SLC24A3;SLC8A3;SLC3A2
prerank,nucleotidase activity (GO:0008252),-0.436854648883244,-1.0764789891894502,0.3841698841698842,0.717486427188588,1.0,9/15,40.11%,NT5E;NT5DC3;NT5C1A;NT5C2;NT5C;ACP3;NT5C3B;NT5DC2;NT5C3A
prerank,DNA polymerase activity (GO:0034061),-0.39373229610003546,-1.0760104680383484,0.3787575150300601,0.7144523906071442,1.0,9/22,29.85%,REV1;POLM;POLH;POLI;CHRAC1;POLE2;POLA1;POLD1;POLE3
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3972240153628439,-1.0746720349923524,0.37375745526838966,0.7137591656417457,1.0,9/21,29.85%,REV1;POLM;POLH;POLI;CHRAC1;POLE2;POLA1;POLD1;POLE3
prerank,protein phosphatase activator activity (GO:0072542),-0.45694139491272195,-1.0746695832785789,0.3961904761904762,0.7097326157211142,1.0,5/13,18.59%,IGFBP3;PTPA;CALM2;CALM1;PPP2R5C
prerank,chemorepellent activity (GO:0045499),-0.3853920193594106,-1.0746695218419648,0.38556701030927837,0.7057453538350406,1.0,6/25,3.63%,EPHA7;SEMA3D;SEMA6A;SEMA3C;DPP4;SEMA7A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4796427094758567,1.0740006097189554,0.38144329896907214,0.711649797382905,1.0,3/15,5.46%,SLC1A5;SLC1A4;SLC25A13
prerank,semaphorin receptor binding (GO:0030215),0.44347448885163304,1.072003249500542,0.394990366088632,0.7115191203011229,1.0,6/23,4.91%,SEMA6D;SEMA5A;PLXNB1;SH3BP1;SEMA6C;RIT2
prerank,hyaluronic acid binding (GO:0005540),-0.4803881227446306,-1.0699591979556895,0.38446969696969696,0.7136679982198362,1.0,4/10,25.35%,CEMIP;LAYN;LYVE1;CD44
prerank,acetylation-dependent protein binding (GO:0140033),-0.40836127034550007,-1.0683603392722152,0.4008097165991903,0.7098809528416266,1.0,6/20,9.77%,TAF1;MLLT3;TRIM24;BRD7;ZMYND8;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),-0.40836127034550007,-1.0683603392722152,0.4008097165991903,0.7098809528416266,1.0,6/20,9.77%,TAF1;MLLT3;TRIM24;BRD7;ZMYND8;CARM1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4456553994563385,1.0680484680539988,0.38188976377952755,0.7155869788075461,1.0,7/21,10.00%,WASF3;AKAP1;AKAP6;ARFGEF1;RYR2;WASF2;AKAP7
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.49603974076712565,1.0669486120441327,0.3940677966101695,0.7138877814924353,1.0,2/11,3.40%,SLC19A1;SLC25A25
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.43472087623709454,-1.0668202032228185,0.396584440227704,0.709794730281699,1.0,3/15,10.60%,SLC26A7;SLC26A2;SLC39A8
prerank,protein phosphatase 1 binding (GO:0008157),0.4420715649958401,1.066282994245883,0.3883495145631068,0.7112085290187272,1.0,2/21,2.09%,SMTNL2;AKAP11
prerank,myosin II binding (GO:0045159),-0.4785644457835661,-1.0654068960293963,0.3898305084745763,0.7093909219959305,1.0,4/10,14.92%,GSN;SHROOM4;TRIOBP;LLGL2
prerank,ferrous iron binding (GO:0008198),-0.3964913927636544,-1.0593909827734802,0.3807615230460922,0.7200448354038412,1.0,14/21,38.48%,EGLN2;EGLN3;FTL;DNAJC24;FTO;FTH1;TET2;EGLN1;CDO1;HIF1AN;ACP5;HAAO;PHYH;HEPH
prerank,ephrin receptor binding (GO:0046875),0.4419815863293929,1.0573431967263562,0.38857142857142857,0.7252475654625,1.0,5/21,13.16%,CHN1;ANKS1B;LYN;SRC;PTPN1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.26426314942251394,-1.0542086554128614,0.29856115107913667,0.7289394031477564,1.0,40/181,15.41%,SMAD3;HDAC4;MDFIC;ANXA4;KLF4;TACC2;TCF7L2;NFATC1;TAF1;ZFPM2;PARP9;ARNT2;WWP2;AR;PRRX1;RERE;GTF2I;BHLHE40;ATN1;MAPK14;LMO2;STAT1;STAT3;IFI27;FIZ1;DTX3L;BBS7;HIF1A;BHLHE41;HDAC1;RELA;PPARA;ID2;MEF2A;HDAC5;TAL1;ACTB;HIPK2;TAF4B;ZFPM1
prerank,ligand-gated anion channel activity (GO:0099095),0.47143041347723696,1.0536081556558,0.4090909090909091,0.7285761225265729,1.0,7/17,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GLRB;GABRB2
prerank,estrogen receptor binding (GO:0030331),0.4110249085933215,1.0531381189044628,0.38649155722326456,0.725584583806738,1.0,8/32,10.15%,RERG;PPARGC1B;TACC1;ARID5A;PADI2;NCOA6;MED1;STRN
prerank,TBP-class protein binding (GO:0017025),-0.3947849064354274,-1.051278622524114,0.394392523364486,0.7323024297103509,1.0,9/21,26.26%,ESR1;TAF1;AHR;YEATS2;HHEX;BRF2;PSMC2;PSMC5;TAF11
prerank,protein phosphatase binding (GO:0019903),0.3368206504170375,1.0510031952322032,0.3736434108527132,0.7259132500293917,1.0,16/117,10.22%,ITGA1;SMTNL2;MAP3K5;PTK2;PIK3R1;AKAP11;ADCY8;MYO16;JAK1;ROS1;ANKLE2;TRAF3;PTPRT;PPP1R16A;STRN;KIF3A
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.46765395641275376,1.0503575375256429,0.40973630831643004,0.7233172673562096,1.0,3/16,5.46%,SLC1A5;SLC1A4;SLC25A13
prerank,protein serine/threonine kinase activity (GO:0004674),0.2966869584948488,1.0492009417766737,0.34600760456273766,0.7217207905842641,1.0,59/334,11.50%,MAST4;MAP3K20;KALRN;CDK6;MAP3K5;MYLK;SNRK;PKN1;MARK1;HUNK;NUAK2;ROCK1;AKT3;LIMK1;RPS6KA4;GRK3;CDK15;CDC42BPA;STK39;STK38L;SRPK3;RPS6KB2;MINK1;CSNK1G1;RPS6KA2;TESK2;MYLK4;TESK1;TTBK1;TAOK3;SIK1;PAK6;PIKFYVE;RIPK2;STK24;STK3;MTOR;ALPK1;GRK5;ACVR2B;MARK2;MAP4K4;PRKD2;CSNK1E;MAP4K1;PAK5;PRKD3;PDIK1L;MAPK10;NEK6;ATR;DYRK3;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PAK1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.49217783877215265,1.0489823085982724,0.4134419551934827,0.7183129042238806,1.0,3/14,9.84%,NCF2;NCF1;NOX3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.491485753459987,1.045528588175882,0.41379310344827586,0.7214482799936175,1.0,2/11,3.19%,PABIR1;PPP1R14A
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4484035855721924,-1.0437651968982555,0.4087301587301587,0.746726528357701,1.0,3/12,11.09%,PIEZO2;PIEZO1;TMC6
prerank,PDZ domain binding (GO:0030165),-0.3065443194893718,-1.0425362687882334,0.37468354430379747,0.7459509799846114,1.0,18/61,12.75%,TGFBR3;DOCK4;CXADR;FZD2;SNTG2;ARHGAP29;SYNJ2;SLC22A4;USHBP1;ERC1;FZD4;ACOX1;FZD7;SLC22A5;TBC1D10A;F11R;CLCN3;CCDC88C
prerank,neurexin family protein binding (GO:0042043),0.5072023729506194,1.0407527760447333,0.42857142857142855,0.72737608657696,1.0,1/10,0.66%,CEL
prerank,SUMO binding (GO:0032183),0.4778971388932932,1.040318872982581,0.4073275862068966,0.724406179657944,1.0,2/13,3.78%,USP25;UBA2
prerank,DNA-binding transcription factor binding (GO:0140297),-0.2612566976875297,-1.037418833783207,0.38545454545454544,0.7545426636184922,1.0,41/189,13.79%,SMAD3;HDAC4;FHL2;HDAC7;KLF4;TCF7L2;TLE4;NFATC1;TAF1;HDAC9;SKI;ZFPM2;WWP2;AR;CREM;YAP1;PRRX1;RERE;GTF2I;BHLHE40;ATN1;PRDM16;LMO2;STAT1;STAT3;IFI27;FIZ1;BBS7;TLE2;ZMYND8;TLE1;BHLHE41;PRDM5;HDAC1;RELA;PPARA;ID2;MEF2A;USF1;HDAC5;TAL1
prerank,tau-protein kinase activity (GO:0050321),0.4399051746147838,1.0372842827859616,0.40234375,0.7265930208299014,1.0,9/20,18.48%,MARK1;ROCK1;TTBK1;MARK2;BRSK1;PRKAA1;CDK5;GSK3B;MARK4
prerank,tau protein binding (GO:0048156),0.3838877003620516,1.0337966450265723,0.40142095914742454,0.7299773051226628,1.0,18/40,22.58%,MAP2;MARK1;ROCK1;TTBK1;SNCA;BIN1;MARK2;BRSK1;EP300;DCTN1;PRKAA1;CDK5;GSK3B;MARK4;STUB1;PPP2CB;PICALM;LGMN
prerank,sodium channel regulator activity (GO:0017080),0.3990446231315889,1.0329968100804983,0.4018348623853211,0.7278311024526918,1.0,9/37,11.62%,NEDD4L;FGF12;FXYD2;FGF13;PRSS8;SCN2B;RANGRF;FGF11;FGF14
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.44191065096595117,-1.0306663874917898,0.42857142857142855,0.7673836321551842,1.0,7/12,38.24%,KDM7A;KDM3A;HR;KDM1A;JMJD1C;KDM4A;PHF2
prerank,retinoic acid receptor binding (GO:0042974),0.43939246233817647,1.0305537839410568,0.432,0.7289285139134181,1.0,7/17,17.06%,TACC1;ACTN4;ARID5A;NCOA6;MED1;CNOT1;NRIP1
prerank,translation elongation factor activity (GO:0003746),-0.42024672699238474,-1.028197321954799,0.43333333333333335,0.7698358718743348,1.0,5/14,16.81%,EEF1A1;EIF5A;EIF5AL1;EEF1B2;EEFSEC
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.47397063342464896,1.022802219513367,0.44298245614035087,0.7406784937943108,1.0,2/12,3.40%,SLC19A1;SLC25A25
prerank,poly-pyrimidine tract binding (GO:0008187),0.4209075353266909,1.02105237534228,0.4384920634920635,0.7405906574196695,1.0,10/23,18.10%,RBMS3;SSB;RBMS1;PABPC4;DAZAP1;HNRNPU;HNRNPC;DIS3L2;FMR1;MCRS1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3976069283358197,1.0193547372244964,0.4601941747572815,0.7404275863882007,1.0,8/35,12.52%,PTK2;PEAK1;FRK;CSK;LYN;ABL2;TEC;SRC
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.35879973389482295,-1.0121317704051416,0.4583333333333333,0.8062047172405107,1.0,8/28,15.77%,LRRK2;MAP2K6;MAPK14;MAP2K5;AKT1;PRKCG;MAPKAPK3;PRKAA2
prerank,RNA binding (GO:0003723),-0.21677041494690383,-1.0114567031648252,0.38461538461538464,0.8039384789755958,1.0,397/1321,26.57%,CELF2;MSI2;SAMD4A;DCN;ROCK2;BICC1;AHNAK;NSA2;FNDC3B;RBFOX2;HOXB6;STRBP;MACF1;VIM;RBMS2;DIAPH1;MBNL1;ANXA2;MYO18A;GOLGB1;LBR;ASCC3;EZR;CAST;PLEC;RPS14;CMSS1;LARP4B;DDX5;RBM47;DDX60;RBM20;RPL9;TUT4;MOV10;SERPINH1;RPS12;THRAP3;TUT7;LUC7L;EDC3;P4HB;RPL41;SRRM2;RPS20;CAVIN1;SIDT1;NUDT4;HDLBP;TES;DDX6;SSBP1;CHD3;NYNRIN;RPL18A;RARS2;STAT3;AFF2;RPS13;RPS19;CPEB2;RPS23;SRBD1;RPS4X;CCDC9;LARP1B;TFRC;TEP1;NOCT;SIDT2;ZYX;TMSB4X;IFIT2;RPS11;RTF1;IGF2BP2;ARHGEF1;POLR2A;EIF4A1;TPT1;UTP14A;RPL13;RC3H2;NOVA2;ACO1;MKRN2;SMG6;MYH10;SON;RPL18;ZFR2;FAM120A;SORBS2;COL14A1;RPS9;EIF2S2;EEF1A1;DENR;RPL34;RPL32;REXO4;OAS2;NAF1;PINX1;PCBP2;KRR1;RBM33;VIRMA;UTP11;CTNNA1;RPL27A;RPS8;IFIT3;RPL12;ATXN2;IFIT1;FAM120C;RPL37;SAMHD1;KARS1;USO1;ZC3H12A;RBM10;FKBP4;DHX32;EIF5A;ANXA7;MTPAP;NXF1;NDUFV3;TDRD3;NOP58;SLC3A2;RPL11;RPS18;RBM42;ANXA11;PUM1;ERI3;EIF4G3;ADD1;TRIP6;PFN1;SUCLG1;CKAP4;CARS1;RPL39;RPS5;RPS16;STRAP;RPL24;NME1;LRRFIP1;RPS15A;HELZ;ELP1;UTP6;MBNL2;CPEB3;ISG20L2;ACTN1;GRSF1;CHD2;TCOF1;TENT5A;NOVA1;YBX3;RPL28;SRSF10;FNDC3A;RPS24;RAN;SF3B6;CALR;RPS27;RPL14;DDX49;RPL26;FAU;LARP1;LRRC47;MRPS7;TXN;EIF4A2;CS;SARS1;TUBA1B;RAMAC;RPL10;GEMIN5;PPIA;BYSL;ENO1;RPL7;HSP90AB1;SNIP1;MRPS24;DDX24;SLTM;PRPF3;MAZ;FXR2;SCG3;CHCHD1;EIF5B;RPL10A;AGFG1;ZCCHC17;NUP98;RPL22;RBM34;RPS15;RPS6;XPOT;SPATS2L;RPL23;RPL17;TYW5;GANAB;PDIA3;SNRPF;SEC23IP;G3BP1;MRPL15;XRN1;NKRF;CEBPZ;SLIRP;HMGB2;EBNA1BP2;ELAVL1;RPL31;PPHLN1;PNPT1;RNASEL;TRMT2A;TRNAU1AP;TRMT10B;TNRC6A;SRSF2;SNRPD1;SNRPD2;SMG5;ELAC2;HNRNPUL2;HNRNPAB;RPS25;NOL12;SNRNP40;PSIP1;TOE1;TPR;RPL15;RPSA;PNLDC1;LSM5;DYNC1H1;RPS7;SRSF6;RRP8;KCTD12;PARK7;PSMD4;EIF4E2;RPL38;MRPL39;RPLP0;HSP90B1;RPL27;CSDC2;PTBP3;ZFP36L2;HMGN5;EIF1B;AGO1;PPARGC1A;UNC50;VCP;PABPC4L;NAT10;LGALS1;CANX;TEFM;SF3B5;TFB1M;ESF1;RCC1L;POLRMT;PNO1;RRBP1;NONO;SMC1A;UBTF;ERH;TENT4B;RPL36A;DDX55;DICER1;DRG2;RRP12;FARSA;USP36;ZC3H18;HNRNPL;CCDC86;SRPK1;RPP38;SAMSN1;MRPL12;MRPL1;PURG;RRP7A;PCBP4;FTSJ3;TCF20;RBBP6;SEC61B;SRF;NELFCD;RPS26;DZIP3;UTP23;ASS1;TOP2A;RPS27L;LRRC59;SRSF5;WRAP53;NUDT16;TUBB4B;LYAR;HSPA9;RPL35A;ALDOA;WBP11;MRPS26;DHX34;FIP1L1;DSP;TRUB2;CSDE1;DNAJC21;HELZ2;EXOSC7;SAMD4B;APEH;DHX8;RDX;CCDC47;SF3A3;BRCA1;RPL8;USP10;YWHAE;RPL36;MTHFSD;EIF3B;POLR2G;CDK11B;ALKBH5;CELF5;FASTKD5;ZNF326;MEX3A;LSM7;SRSF11;RRS1;SRPK2;RPS3;PEG10;ZBP1;S100A16;DNAJC2;ACIN1;MRPL4;HNRNPF;RACK1;HNRNPA0;ZNF106;CPNE3;NUDT1;RPL13A;ZC3H12B;FBL;POP1;NHP2;MRPL21;EIF2AK4;ABCF1;MRPL54;PUF60;G3BP2;RPUSD4;DDX54;CLK3;RBMX2;PEBP1
prerank,zinc ion binding (GO:0008270),-0.24045185223645543,-1.01091337628968,0.4225941422594142,0.8010127240368803,1.0,82/293,20.85%,SMAD3;KDM7A;HDAC4;GLI2;PAM;PAPPA;EEA1;ENPP1;MYRIP;SHANK3;NPEPPS;SEC23A;SEC24D;TIMP2;KLF4;ARHGEF2;TRIM24;SKI;ZFPM2;TNFSF10;ACE;ENPP3;KDM5B;TET3;TES;SEC24A;SORD;ACER3;CHD3;RNPEP;ERAP1;UPB1;P2RX4;BAZ1B;DUSP12;LNPEP;DPP3;ZMYND8;IDE;SAMHD1;DNAJC24;NSD1;GCH1;ADAMTS3;RNF125;MDM2;NUDT12;CALR;RPS27;PLA2G15;ADH1A;MSRB3;ADAM33;GDA;SMPDL3A;TIMM13;TRIM8;SIRT2;FBXL19;SIRT3;ZCCHC4;TIMM8B;MT3;ZFYVE1;PIAS4;CTCF;CALB1;GLO1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;FNTB;ZDHHC15;TIMM9;THAP1;ENPP2;PHEX
prerank,ATPase activator activity (GO:0001671),-0.3836705916142376,-1.010514656630088,0.45525291828793774,0.7978669657347728,1.0,7/20,18.31%,ATP1B3;TOR1AIP1;DNAJB2;DNAJC24;DNAJB6;DNAJC15;DNAJC10
prerank,protein heterodimerization activity (GO:0046982),-0.25744814090568735,-1.0074518780937134,0.4233576642335766,0.8018098261164605,1.0,60/178,25.85%,BMP6;EXT1;TCF4;TAF1;ITGA3;ZHX3;SDCBP;IRAK2;ARNT2;HEXA;BHLHE40;P4HB;BDKRB2;TOP2B;FZD4;ADRA1B;MCL1;HIF1A;KCNB1;NR4A2;ATF6;BHLHE41;IRAK3;ADD1;AHR;TCOF1;MEF2A;USF1;SAE1;RAN;CYBA;ATP1A1;RALGAPA2;FXR2;VAPA;UBA3;MICU2;SMC3;TLR4;USF2;LSM5;AGTR1;MICU1;IKBKG;YWHAH;SMC1A;CYBB;XBP1;TOP2A;SNX2;PAFAH1B1;ABCG4;TRMT112;YWHAE;MIGA1;BCL2L1;ATF3;RRAGC;NR4A1;TP53
prerank,actinin binding (GO:0042805),0.4334978605247402,1.0060766200992597,0.45286885245901637,0.762873594982981,1.0,1/21,0.34%,CACNA1C
prerank,O-acyltransferase activity (GO:0008374),0.40821305533254926,1.0058834570216175,0.4540441176470588,0.7594691342072595,1.0,3/30,7.18%,MBOAT2;MBOAT4;PLAAT1
prerank,galactosyltransferase activity (GO:0008378),-0.43665229978126396,-1.0053181247418366,0.4731800766283525,0.8030119746954493,1.0,2/11,5.00%,B4GALT1;A4GALT
prerank,protein kinase inhibitor activity (GO:0004860),0.38293265458648235,1.0043990204853597,0.4388888888888889,0.7587510452935432,1.0,9/42,10.76%,SPRY4;SPRED1;SPRY2;HEXIM1;SNCA;TAOK3;CDKN1A;INKA2;PRKRIP1
prerank,retinoic acid binding (GO:0001972),-0.43319259151932754,-1.0031737611052278,0.46741154562383613,0.8045231408716128,1.0,3/12,26.11%,CYP26B1;RARA;RXRA
prerank,potassium:proton antiporter activity (GO:0015386),-0.44491592660941987,-1.000509110783336,0.4864376130198915,0.8073984957781869,1.0,3/10,17.51%,SLC9A2;SLC9A9;SLC9A1
prerank,nuclear export signal receptor activity (GO:0005049),-0.4406375990382791,-1.0002820254454523,0.5189393939393939,0.8038861189958344,1.0,7/11,30.30%,RAN;NUP214;XPO4;RANBP17;EIF4ENIF1;CSE1L;XPO5
prerank,SUMO transferase activity (GO:0019789),-0.4054035812583008,-0.9998193456903838,0.4835589941972921,0.8010308798104072,1.0,5/16,24.62%,HDAC4;MDM2;CBX4;PIAS4;PIAS3
prerank,GTP binding (GO:0005525),0.30104499408133023,0.9997815410257059,0.42997198879551823,0.763902175054037,1.0,17/172,8.86%,RASL12;REM1;RERG;RND3;AGAP2;RRAD;NOA1;RAC3;RIT2;TUBA8;ARL4C;RAP1A;HRAS;TUBB2B;RAB28;RAB38;RNF112
prerank,microtubule binding (GO:0008017),0.2926114707588523,0.999199911559296,0.449468085106383,0.7613641484787284,1.0,32/222,11.88%,SGIP1;STARD9;MAP2;MTCL1;RMDN1;SPEF1;MID2;SVBP;FGF13;NAV3;GAS8;CLASP2;MAPRE2;TPPP;STIM1;KIF26B;HOOK3;FAM161A;MAP4K4;CLIP2;NUSAP1;KIF3A;UXT;CAMSAP3;TOGARAM2;MACO1;TPGS1;CCDC66;KIF20A;KIF5C;APC;KIF3C
prerank,thyroid hormone receptor binding (GO:0046966),0.39776302249800227,0.9990713652910823,0.4344422700587084,0.7579411173507373,1.0,10/28,18.02%,NCOA3;TACC1;MED13;ARID5A;NCOA6;MED1;MED4;GTF2H1;HMGN3;MED30
prerank,antiporter activity (GO:0015297),-0.37458148004935404,-0.9982007972527365,0.4672897196261682,0.8010528584469019,1.0,5/20,16.02%,TMEM241;CLCN3;ATP1A3;SLC35D2;SLC35E4
prerank,protein kinase binding (GO:0019901),0.27618595063848395,0.9974620101205411,0.4481955762514552,0.7574925563226125,1.0,52/479,8.76%,PTPRK;PDGFRB;CSPG4;UTRN;LIMS1;SLC12A2;PRKCSH;IL15RA;PTK2;RGCC;PKN1;BCAR1;PRKAR1B;FERMT2;RND3;SPRED1;AGAP2;WAS;PTN;FOXM1;DOK7;SH2B3;PKIA;GRM5;RAC3;ADCY6;PDCD10;NBEAL1;STK11IP;SPDYA;SPRY2;TRIB2;SCN5A;ITGB1;TNIP2;SYN1;PRKAR2B;RYR2;SIK1;APPL1;KIZ;CASP9;YWHAZ;EMP2;IRS1;CDKN1A;PPP1CC;PRKAR2A;GRK5;SHC4;RAB11FIP2;CSK
prerank,cell adhesion mediator activity (GO:0098631),0.4019126193980328,0.9937361363227596,0.4356060606060606,0.7609449351287392,1.0,7/24,13.51%,JAM3;LRRC4C;ESAM;CNTN4;CNTN6;PLXNB3;DSCAM
prerank,kinase binding (GO:0019900),0.27826677721321585,0.9933243420088498,0.466824644549763,0.7579692700015238,1.0,37/434,6.88%,PTPRK;PDGFRB;CSPG4;UTRN;LIMS1;SLC12A2;IL15RA;PTK2;RGCC;BCAR1;TNS2;FERMT2;RND3;SPRED1;AGAP2;WAS;PTN;FOXM1;ATP1A4;PTPN22;DOK7;ABI2;RAC3;ADCY6;PDCD10;NBEAL1;STK11IP;SPDYA;SPRY2;SCN5A;TNIP2;SYN1;SIK1;KIZ;CASP9;YWHAZ;EMP2
prerank,heme binding (GO:0020037),0.3447689061871651,0.9932167200539634,0.45806451612903226,0.7545102222592747,1.0,1/65,0.12%,GUCY1B1
prerank,cytokine receptor binding (GO:0005126),-0.28272464331450486,-0.9925406713147801,0.45454545454545453,0.8112917964233551,1.0,16/83,12.04%,TGFBR3;SMAD3;IL6R;IL6ST;CSF1;SOCS2;VEGFD;SDCBP;VEGFC;CXCL12;FKBP1A;ERAP1;USP15;IL18;TRIP6;CCL25
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.44362556085087085,0.9921240644051886,0.47520661157024796,0.7530451611961753,1.0,4/18,10.26%,PIK3R1;AGAP2;SOCS5;SOCS6
prerank,histone deacetylase binding (GO:0042826),0.3333979341402422,0.9910837380321883,0.46029173419773095,0.7516029605279025,1.0,5/88,3.98%,MEF2C;HEY2;PRDM1;PKN1;MIER1
prerank,androgen receptor binding (GO:0050681),-0.36059321628952556,-0.9900030395187427,0.4864864864864865,0.8137933445948143,1.0,7/25,13.04%,FOXP1;DDX5;TMF1;PRKCB;KDM3A;NSD1;CALR
prerank,tumor necrosis factor receptor binding (GO:0005164),0.45625706441189523,0.9899872101070395,0.45517241379310347,0.7503395933181581,1.0,5/12,16.09%,TRAF5;TRAF3;TRAF6;TRAF2;TRIM37
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3956825205582846,0.9875446456144724,0.4684512428298279,0.7516704307462537,1.0,5/29,5.46%,SLC1A5;SLC1A4;SLC19A1;SLC26A1;SLC25A13
prerank,poly(U) RNA binding (GO:0008266),0.4185340418816965,0.9874975248838751,0.47474747474747475,0.7482287341981774,1.0,9/20,18.10%,RBMS3;SSB;RBMS1;PABPC4;DAZAP1;HNRNPC;DIS3L2;FMR1;MCRS1
prerank,ankyrin binding (GO:0030506),0.4315019260353272,0.9853348068010127,0.4612159329140461,0.7490902593546689,1.0,5/19,7.38%,SPTBN1;SPTB;SCN5A;KCTD6;CACNA1D
prerank,magnesium ion binding (GO:0000287),0.3096248239496907,0.9847551459006539,0.45977011494252873,0.746792488375383,1.0,22/135,11.79%,MAP3K20;MAP3K5;SNRK;MARK1;NUAK2;CIB3;CDC42BPA;UBA2;STK38L;SNCA;TPPP;SIK1;PAPOLA;MTHFD2;STK3;MARK2;NEK6;DYRK3;ABL2;BRSK1;SRR;NLK
prerank,E-box binding (GO:0070888),0.3827906219085578,0.9843241227943423,0.4634615384615385,0.7441101618983296,1.0,6/34,11.05%,ZEB1;TCF15;SCRT2;SREBF2;MITF;SNAI2
prerank,cytokine activity (GO:0005125),-0.25736170673755493,-0.9801116565239603,0.49390243902439024,0.8343651406617654,1.0,19/131,12.10%,BMP6;WNT4;BMP7;IL15;WNT6;BMP4;CSF1;WNT9A;TNFRSF11B;IL16;CXCL12;WNT5A;CCL15;CCL14;IL33;IL18;TGFB1;CCL25;WNT5B
prerank,methylation-dependent protein binding (GO:0140034),-0.2966140197145165,-0.9793397775017467,0.4523809523809524,0.8323418773471492,1.0,29/57,38.25%,KDM7A;TRIM24;BPTF;ZMYND8;TDRD3;NCAPG2;MORC4;L3MBTL2;RRP8;MPHOSPH8;ZMYND11;SGF29;MSH6;PYGO1;ING4;L3MBTL1;ZCWPW1;CBX2;MBTD1;MORC3;RBBP5;JMJD7;CBX8;ATRX;UHRF1;KDM4A;KMT2E;PHF2;PHF1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.43716171545046284,-0.974716381073776,0.5185873605947955,0.839733271074739,1.0,6/10,31.35%,BRCA2;NAA40;USP22;HAT1;ATF2;NAA60
prerank,protein kinase C binding (GO:0005080),-0.3152778650302262,-0.9731690523473605,0.5186915887850467,0.8396144045387649,1.0,12/43,13.94%,PDLIM5;HDAC7;CAVIN2;ADAM9;HDAC9;PARD6G;PRKCB;TOP2B;HINT1;TRPV4;HDAC5;CAVIN3
prerank,double-stranded RNA binding (GO:0003725),-0.28912307819860017,-0.972243318437855,0.4797979797979798,0.838000743622546,1.0,16/70,14.30%,STRBP;VIM;MBNL1;DDX60;SIDT1;TFRC;SIDT2;EIF4A1;RC3H2;ZFR2;OAS2;SLC3A2;LRRFIP1;ACTN1;TUBA1B;HSP90AB1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3256318852170239,-0.9721750081597376,0.490280777537797,0.8341717617485302,1.0,8/34,16.18%,IQGAP1;IGF2;CALM2;ALS2;IRGM;DBF4;PARP16;CALM1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.4540533836330787,0.972167827678461,0.475103734439834,0.7642820658362738,1.0,2/12,6.79%,ATP2A3;BCL2L13
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3392885830821558,-0.9721007499657597,0.50199203187251,0.8304192566577745,1.0,11/27,25.65%,RNF19A;RNF144B;RNF125;PPARA;ANKIB1;UBE3D;RNF217;RNF144A;RNF19B;FOXL2;PRKN
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.45151967546292443,0.9719516561171921,0.4816414686825054,0.7611682838983337,1.0,4/11,12.93%,ITPR1;RYR2;RYR3;RASA3
prerank,methylated histone binding (GO:0035064),-0.2902818598432298,-0.9716258809911696,0.5136476426799007,0.8276420015287977,1.0,22/62,28.16%,KDM7A;TAF1;TRIM24;BPTF;ZMYND8;TDRD3;NCAPG2;MORC4;L3MBTL2;RRP8;CHD5;MPHOSPH8;ZMYND11;SGF29;MSH6;PYGO1;ING4;L3MBTL1;ZCWPW1;CBX2;MBTD1;MORC3
prerank,DNA secondary structure binding (GO:0000217),0.3785469988253804,0.9640580064701769,0.4807692307692308,0.7735959530734017,1.0,1/31,0.63%,MEF2C
prerank,clathrin adaptor activity (GO:0035615),-0.39041865524895447,-0.9631574845397053,0.5291902071563088,0.8442911805382127,1.0,3/15,5.05%,DAB2;STON2;AP2A2
prerank,alpha-actinin binding (GO:0051393),0.4055200713242808,0.9615929662576838,0.4970414201183432,0.7745677625940142,1.0,4/24,9.02%,CACNA1C;PDLIM1;CACNA1D;PKD2
prerank,peptidoglycan binding (GO:0042834),-0.44129728348666675,-0.961420908766389,0.5553505535055351,0.8447387401385452,1.0,2/10,9.38%,NOD1;PGLYRP1
prerank,hexose transmembrane transporter activity (GO:0015149),0.4347734089089846,0.9600659879276483,0.4666666666666667,0.7740851644144885,1.0,3/12,8.28%,SLC5A1;SLC2A6;SLC2A3
prerank,protein phosphatase 2A binding (GO:0051721),-0.35637514477842464,-0.957481659531215,0.5299806576402321,0.850476355403224,1.0,7/23,16.96%,FOXO1;CTTNBP2NL;MFHAS1;PTPA;DAB2IP;SPHK1;SMG5
prerank,glutamate receptor binding (GO:0035254),-0.3675751938652747,-0.954318034330066,0.517578125,0.8544778743059054,1.0,6/17,17.12%,SHANK3;GNAS;CAMK2A;SHISA7;HOMER1;HOMER3
prerank,calcium-activated potassium channel activity (GO:0015269),0.45339950043265875,0.9505000677214854,0.49145299145299143,0.7886056770635919,1.0,3/11,14.12%,KCNMB1;KCNMA1;KCNU1
prerank,amyloid-beta binding (GO:0001540),0.3302828931960672,0.9503357549461571,0.5171288743882545,0.7853725102918621,1.0,13/79,10.24%,CLSTN1;APBB2;FZD6;LDLRAP1;LDLR;MSR1;GRIA2;CHRNA7;ACHE;ITM2B;GRIN2B;CACNA1A;APBA2
prerank,small GTPase binding (GO:0031267),0.2885506397773384,0.9485835775068941,0.5390070921985816,0.7853658607769958,1.0,29/169,11.50%,EPS8;PLCE1;RAPGEF4;TNFAIP1;PKN1;ARHGAP1;WAS;CHML;ABI2;RIMS1;RTKN;TBC1D30;AP1G1;PEX5L;IFT20;GGA3;RIC1;HACE1;LZTR1;ARHGDIB;KCTD13;MTSS2;NCKAP1;BICD2;KIF3A;BRAF;RANGRF;DENND10;PAK1
prerank,snRNA binding (GO:0017069),0.35198372995346916,0.9466545945204834,0.4973637961335677,0.7856273651420473,1.0,13/42,17.68%,HEXIM1;NCBP2;LSM10;SART3;RBM7;HNRNPU;LSM8;COIL;PRPF31;SF3B3;SNRPD3;LSM2;LARP7
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.4409506231208976,0.9459555428326137,0.5022026431718062,0.7834551457918882,1.0,6/10,10.18%,PRKAR1B;PKIA;CXCL10;PRKAR2B;PRKAR2A;PRKAR1A
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.43695484536419243,0.9450730719225385,0.5052631578947369,0.7817545750958182,1.0,2/14,6.79%,ATP2A3;BCL2L13
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4042074579951927,-0.9429509243867576,0.5238095238095238,0.8781739043131989,1.0,3/10,14.54%,SHANK3;GNAS;SHISA7
prerank,ubiquitin protein ligase activity (GO:0061630),-0.22942963615046105,-0.942494759811848,0.6532258064516129,0.8752880606105903,1.0,49/228,16.97%,RNF220;PDZRN3;SH3RF1;SMURF2;RNF38;ZNRF1;KCMF1;ASB2;RNF43;TRIM24;RNF130;RNF19A;WWP2;RNF144B;RNF139;SMURF1;SH3RF3;SH3RF2;AMFR;BIRC3;RC3H2;NHLRC3;MKRN2;RNF185;DTX3L;RNF135;MGRN1;ZNRF3;TRIM27;UBE4B;RNF125;MDM2;TRIM63;TRIM35;BRAP;RNF181;TRIM39;DTX1;TRIM17;NEURL2;RNF115;RNFT2;WWP1;ANKIB1;RNF187;ASB1;UBR4;PELI1;UBE3D
prerank,GABA receptor activity (GO:0016917),0.40004360902674074,0.9415101276161508,0.5092402464065708,0.7852819659578002,1.0,7/21,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABBR2;GABRB2
prerank,mannose binding (GO:0005537),-0.39923925747488614,-0.9402441869034712,0.5401174168297456,0.8769437364885918,1.0,6/12,46.36%,LMAN1;CLN5;ACR;COLEC11;LMAN1L;CLEC4D
prerank,mRNA binding (GO:0003729),-0.2299839482494025,-0.9402085505804293,0.6514522821576764,0.8730587941567778,1.0,60/249,19.28%,CELF2;SAMD4A;RBFOX2;RBMS2;RPS14;LARP4B;DDX5;RBM47;RBM20;LUC7L;EDC3;RPL41;SRRM2;HDLBP;DDX6;NYNRIN;RPS13;CPEB2;SRBD1;NOCT;IGF2BP2;EIF4A1;RC3H2;NOVA2;ACO1;MYH10;EIF2S2;DENR;PCBP2;ZC3H12A;PUM1;EIF4G3;RPS5;CPEB3;GRSF1;NOVA1;YBX3;SF3B6;CALR;RPL26;LARP1;MRPS7;AUH;GEMIN5;RPL7;SNIP1;FXR2;NUP98;G3BP1;ELAVL1;RNF40;HNRNPAB;TPR;RPS7;SRSF6;PARK7;TYMS;CSDC2;PTBP3;PABPC4L
prerank,5'-3' exonuclease activity (GO:0008409),0.42818940111203435,0.9381124501149101,0.513978494623656,0.7885234836094632,1.0,3/14,10.41%,DCLRE1B;XRN2;TRIR
prerank,gated channel activity (GO:0022836),-0.3894157741135713,-0.9364678751797685,0.5476190476190477,0.8776540779277363,1.0,3/14,11.09%,PIEZO2;PIEZO1;TMC6
prerank,acetyltransferase activity (GO:0016407),-0.3241177087165448,-0.936341384982718,0.5681818181818182,0.873896415492427,1.0,8/31,21.28%,KAT6B;KAT2B;SPHK1;PAFAH2;ELP3;NAT10;SAT1;NAA80
prerank,U6 snRNA binding (GO:0017070),0.4212651935362237,0.933915037804113,0.519916142557652,0.7930156102183815,1.0,5/14,17.68%,LSM3;SART3;LSM8;LSM2;LARP7
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.32324297689948206,-0.9332696634454183,0.5683297180043384,0.8773678897185321,1.0,13/32,24.22%,SLC6A6;SFXN2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC43A1;SLC36A1;SLC1A1;SLC38A1;MFSD12
prerank,protein homodimerization activity (GO:0042803),0.25449950968356233,0.9321427150808462,0.6275626423690205,0.7929068459045002,1.0,66/589,10.38%,ANO1;TRPC6;CASQ2;IMPA2;PTH1R;FAP;RBPMS;MAP3K5;SYNE1;RBPMS2;MTCL1;RDH5;TRIM9;MYH9;DCLRE1B;ERBB4;PLD6;PIP4K2A;ECE1;MID2;ABCD2;BCL2L10;GUCY2D;ADCY8;PDCD10;CRPPA;PEX7;CARD9;ACTN4;TFAP2B;NTRK2;TPPP;SFPQ;CHRNA7;APPL1;PSMF1;RCHY1;SUPV3L1;PADI2;RIPK2;TYR;PTPRT;HMGCS1;ACHE;DCK;STC2;TENM4;CORO1A;RAB11FIP2;ARNT;CIP2A;PKD2;NR2F2;MSH3;PDGFB;ZDHHC2;TARBP2;CR2;CNOT9;MYOM1;EFEMP2;GNPTG;DARS2;HIP1;TBX18;DGKD
prerank,death receptor binding (GO:0005123),-0.383657673180298,-0.9285896939453876,0.545631067961165,0.884494115641243,1.0,9/15,39.47%,DAB2IP;BID;RIPK1;EDA;NTF3;MYD88;FADD;PIDD1;CASP8AP2
prerank,nuclease activity (GO:0004518),-0.28575265313885084,-0.9276532461151201,0.5928411633109619,0.8827910282088776,1.0,12/52,17.38%,ENPP1;RNASE4;N4BP2;ERCC5;REXO4;SAMHD1;ZC3H12A;DNASE1L1;NME1;ISG20L2;RNASEL;RNASE12
prerank,calcium channel inhibitor activity (GO:0019855),-0.41197525735729534,-0.9271738656467824,0.5711645101663586,0.8800478721686359,1.0,5/11,17.40%,CALM2;FKBP1A;MCUB;CALM1;SLC30A1
prerank,chemokine activity (GO:0008009),-0.3236806924391244,-0.9262074149349594,0.5867768595041323,0.8783887145940558,1.0,19/31,43.90%,CXCL12;CCL15;CCL14;CCL25;CXCL16;CCL13;CCL19;CKLF;CCL2;CX3CL1;CCL28;CCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.2244429134480593,-0.9261048524898642,0.7016806722689075,0.8748010899349972,1.0,49/232,16.97%,RNF220;PDZRN3;SH3RF1;SMURF2;RNF38;ZNRF1;KCMF1;ASB2;RNF43;TRIM24;RNF130;RNF19A;WWP2;RNF144B;RNF139;SMURF1;SH3RF3;SH3RF2;AMFR;BIRC3;RC3H2;NHLRC3;MKRN2;RNF185;DTX3L;RNF135;MGRN1;ZNRF3;TRIM27;RNF125;MDM2;TRIM63;CBX4;TRIM35;BRAP;RNF181;TRIM39;DTX1;TRIM17;NEURL2;RNF115;RNFT2;WWP1;ANKIB1;RNF187;ASB1;UBR4;PELI1;UBE3D
prerank,glucose transmembrane transporter activity (GO:0005355),0.3985546785226883,0.9256555059871012,0.5019455252918288,0.8017663554242179,1.0,3/17,8.28%,SLC5A1;SLC2A6;SLC2A3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4217980780419909,0.924996075231213,0.5444915254237288,0.7995375519180091,1.0,5/13,13.49%,TRMT5;TRMT1;THUMPD2;TRMT11;TRMT10C
prerank,ribosomal large subunit binding (GO:0043023),0.4296113765078804,0.9248541610061987,0.5296703296703297,0.796429349029642,1.0,4/11,11.18%,CPSF6;NMD3;MALSU1;EIF6
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3909872689199009,-0.9206850917885966,0.5553435114503816,0.8834768064109897,1.0,6/12,20.84%,CNOT7;NOCT;CNOT8;TOE1;PNLDC1;PAN3
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4172217591122265,0.9184739463867677,0.5290322580645161,0.8051252084349345,1.0,1/13,0.19%,PDGFRB
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3318733242838215,0.9155575579933188,0.5631399317406144,0.8072804933008467,1.0,4/57,5.41%,COX4I2;NDUFA4L2;UQCRFS1;NDUFB2
prerank,microtubule plus-end binding (GO:0051010),0.3905329668355246,0.9142346166994246,0.524896265560166,0.8061837349721707,1.0,9/20,18.77%,CLASP2;MAPRE2;STIM1;CLIP2;APC;DCTN1;CLIP1;DST;KNSTRN
prerank,nuclear receptor binding (GO:0016922),-0.24480115530426536,-0.9134611800424566,0.6629526462395543,0.8958694289821949,1.0,21/111,13.15%,SMAD3;FOXP1;LCOR;ESR1;DDX5;TACC2;TCF7L2;LEF1;TAF1;TMF1;THRAP3;PRKCB;STAT1;HIF1A;NR4A2;MMS19;KDM3A;NSD1;TRIP6;CALR;PPID
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.4417037432291988,0.9130817834354157,0.5505154639175258,0.8050208930260307,1.0,2/10,4.43%,SLCO3A1;SLCO5A1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.371523053682041,-0.9129811745886727,0.5821782178217821,0.8933217284675241,1.0,2/16,2.95%,SLC26A7;SLC26A2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4024375934694664,0.9129083511618211,0.5445736434108527,0.8020137665218328,1.0,1/18,1.67%,RDH5
prerank,telomerase RNA binding (GO:0070034),-0.33606789591456093,-0.9111213050063264,0.594541910331384,0.8936739766843824,1.0,10/22,27.12%,TEP1;SMG6;NAF1;PINX1;XRN1;SMG5;TENT4B;WRAP53;NHP2;SNRPB
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.30093990018046884,-0.9107617864538465,0.6012526096033403,0.8906253782280803,1.0,12/37,20.75%,LARS2;RARS2;KARS1;TARS2;CARS1;QARS1;SARS1;HARS1;MARS2;EARS2;VARS2;FARSA
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4162150583554827,0.9093593128643445,0.5067264573991032,0.8053128827072966,1.0,1/12,1.10%,CDK6
prerank,growth factor receptor binding (GO:0070851),0.29753265204492396,0.9089429548862515,0.5906148867313916,0.8027440768063457,1.0,12/95,10.21%,PDGFRB;GLMN;LINGO1;ERBB4;IL1B;FGF2;IL4;FGF10;IL12RB1;PDGFB;CNOT9;HIP1
prerank,adenyl nucleotide binding (GO:0030554),-0.3974684897429269,-0.9077239740540839,0.5774378585086042,0.8901847809633018,1.0,6/11,28.91%,BAG3;PFN1;BAG2;BAG5;HSPH1;BAG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3974684897429269,-0.9077239740540839,0.5774378585086042,0.8901847809633018,1.0,6/11,28.91%,BAG3;PFN1;BAG2;BAG5;HSPH1;BAG1
prerank,phosphatase binding (GO:0019902),0.2963366454783689,0.9076233986418841,0.578125,0.8019301014603337,1.0,8/105,5.43%,ITGA1;MAP3K5;PTK2;PIK3R1;SPRED1;MYO16;JAK1;ROS1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3726103446391708,-0.9069415375064316,0.5972495088408645,0.8882540410985865,1.0,8/14,37.74%,PRORP;ELAC2;RPP38;TSEN2;POP1;TSEN34;RPP21;RPP40
prerank,GTPase binding (GO:0051020),0.2701382479008907,0.9038961691962655,0.6179310344827587,0.8054217953178151,1.0,31/194,11.50%,EPS8;PLCE1;RAPGEF4;TNFAIP1;PKN1;ARHGAP1;WAS;CHML;SPTBN1;ABI2;RIMS1;RTKN;TBC1D30;AP1G1;PEX5L;IFT20;GGA3;ATG16L1;RIC1;HACE1;LZTR1;ARHGDIB;KCTD13;MTSS2;NCKAP1;BICD2;KIF3A;BRAF;RANGRF;DENND10;PAK1
prerank,acylglycerol lipase activity (GO:0047372),-0.3967476860500394,-0.9016213832577908,0.5859375,0.8964862339186253,1.0,3/11,13.02%,MGLL;LIPE;ABHD16A
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.398559858268352,0.9001829801463309,0.5767634854771784,0.8088077030547359,1.0,6/17,15.63%,CLP1;AK8;AK7;AK5;AK4;AK3
prerank,mRNA methyltransferase activity (GO:0008174),0.4194983740930899,0.8998133075586308,0.5676855895196506,0.8061817945938327,1.0,4/12,17.91%,TRMT61A;RNMT;TRMT10C;NSUN2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.37333513867161494,0.899603118950884,0.5454545454545454,0.8001040578455529,1.0,2/21,3.46%,CDK6;CDK15
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.37333513867161494,0.899603118950884,0.5454545454545454,0.8001040578455529,1.0,2/21,3.46%,CDK6;CDK15
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.28968446412287446,-0.8992419506031747,0.6183035714285714,0.898049804947968,1.0,8/46,11.96%,EXT1;LARGE1;HEXA;HEXB;MGAT1;B3GALNT1;MGAT2;EXTL2
prerank,protein tyrosine kinase activity (GO:0004713),0.2889080445379004,0.8987691806221698,0.6024653312788906,0.7982557246903976,1.0,23/108,12.64%,PDGFRB;ROR1;PTK2;PEAK1;FRK;MERTK;ERBB4;AXL;JAK1;RYK;ROS1;NTRK2;TTBK1;CSK;LYN;EPHA2;ABL2;HIPK1;EPHA10;TEC;EPHB1;SRC;FGFR3
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3634718795331664,-0.8977218274045905,0.6261859582542695,0.8939795913665353,1.0,5/16,15.26%,ATP6V0A4;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3634718795331664,-0.8977218274045905,0.6261859582542695,0.8939795913665353,1.0,5/16,15.26%,ATP6V0A4;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2
prerank,palmitoyltransferase activity (GO:0016409),0.359714240363531,0.8959475339224525,0.5821501014198783,0.8002279547767843,1.0,8/28,13.52%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC16;ZDHHC17;ZDHHC21;ZDHHC23;HHAT
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3006564744658301,-0.8923501493509706,0.6486486486486487,0.9019986212080352,1.0,14/33,25.65%,RNF19A;RNF144B;RNF185;RNF125;PPARA;ANKIB1;UBE3D;PARK7;RNF217;RNF144A;RNF19B;FOXL2;RPS3;PRKN
prerank,transferrin receptor binding (GO:1990459),0.4177126430309539,0.8839884907043264,0.5670103092783505,0.8184445071665313,1.0,1/10,2.07%,RGMA
prerank,fatty acid synthase activity (GO:0004312),-0.39706363089231267,-0.8834891840914473,0.6162162162162163,0.9172913555979573,1.0,3/10,23.82%,ELOVL7;ELOVL1;OXSM
prerank,phosphatase activity (GO:0016791),-0.2540205476535214,-0.8826071377899921,0.7160804020100503,0.9153482984547155,1.0,31/73,29.87%,PLPP3;PTPRJ;ALPL;DUSP12;NOCT;PPP1CB;DUSP16;PXYLP1;PLPP1;EPHX2;PGAM5;LPIN3;PGP;DUSP10;DUSP23;LHPP;PLPP4;CILP;NUDT16;DUSP15;INPP5K;NT5C;PPP5C;CILP2;PLPPR4;ACP3;PLPP2;DUSP26;PPP1CA;DUSP8;DUSP4
prerank,peptidase activator activity (GO:0016504),-0.3255391448472475,-0.8797510202659723,0.6234567901234568,0.9178429164700103,1.0,6/22,22.40%,CAV1;PSME2;PCOLCE;PSME3;VCP;CLPX
prerank,histone demethylase activity (GO:0032452),-0.31639343006072,-0.8789648870543363,0.6652631578947369,0.9155760545822633,1.0,6/27,17.22%,KDM7A;KDM5B;JARID2;KDM3A;KDM6B;FBXL19
prerank,translation initiation factor activity (GO:0003743),-0.28682330935726685,-0.8771505333737147,0.6805555555555556,0.9156325366291228,1.0,16/36,30.58%,EIF4A1;EIF2S2;EIF4G3;MTIF3;EIF4A2;EIF5B;EIF2B2;EIF4E2;EIF1B;EIF2B5;EIF3B;EIF3H;EIF2B4;EIF2D;AGO2;EIF3D
prerank,GTPase activity (GO:0003924),0.2633416610581329,0.876321748434349,0.6834030683403068,0.829510074011765,1.0,20/192,8.86%,RASL12;RERG;RND3;AGAP2;GNAZ;RAB8B;RAC3;RIT2;DNAJC27;RAB3B;DDX3X;TPPP;RAP1A;HRAS;GNG5;RAB28;ARHGDIB;RAB38;GNA12;RNF112
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3962850183469624,0.8750490569117256,0.569672131147541,0.8284653157069689,1.0,3/15,10.26%,PIK3R1;SOCS5;SOCS6
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.28560766199660254,-0.8729270964092293,0.6827731092436975,0.9209061844205892,1.0,9/33,17.78%,CNOT7;NOCT;ERI3;CNOT8;EXOSC5;XRN1;PNPT1;TOE1;PNLDC1
prerank,O-methyltransferase activity (GO:0008171),-0.39425189432549373,-0.8719877610558837,0.6424778761061947,0.9190005464142975,1.0,4/10,32.58%,CMTR1;FTSJ3;ASMT;BCDIN3D
prerank,copper ion binding (GO:0005507),-0.27887156931413865,-0.8712846294052848,0.6740088105726872,0.9167739635505933,1.0,5/42,7.43%,MOXD1;PAM;ATOX1;LACC1;P2RX4
prerank,MHC class II protein complex binding (GO:0023026),-0.38484287500917524,-0.8708156855581195,0.6564195298372514,0.9139844066796918,1.0,4/11,24.44%,ANXA11;HSP90AB1;CD81;YWHAE
prerank,nucleosomal DNA binding (GO:0031492),-0.3254087627119208,-0.8653252497408231,0.6694915254237288,0.9214269107813228,1.0,6/21,22.86%,H3-3A;HDAC1;ACTB;SMARCC1;MBD2;SMARCA4
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.2656782954961496,-0.8638575763143799,0.7216748768472906,0.9209625608762079,1.0,19/49,36.95%,ZFAND6;IKBKE;OPTN;MINDY1;WDR81;PSMD4;BABAM2;VCP;IKBKG;UBXN1;DZIP3;ABRAXAS2;MINDY2;PARP10;HDAC6;AGAP3;RAD23A;TAB2;ZRANB3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.34707929414536215,-0.8635406872573608,0.6699604743083004,0.9179088596735223,1.0,8/16,26.83%,CD38;MACROD1;TDG;ADPRS;NEIL3;RPS3;NEIL1;NTHL1
prerank,microtubule minus-end binding (GO:0051011),-0.3588541106488444,-0.8633144566724944,0.663023679417122,0.9147123010488141,1.0,5/13,29.32%,MACF1;TUBGCP5;NUMA1;CAMSAP1;TUBGCP6
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4143539754710376,0.8609796022213692,0.5906040268456376,0.8506828286407725,1.0,5/10,19.44%,SETMAR;SETD3;NSD2;NSD3;SETD5
prerank,phosphatase inhibitor activity (GO:0019212),0.3748537790519453,0.8597174166121812,0.6224899598393574,0.8496411985100708,1.0,9/20,22.02%,PTN;SET;URI1;MGAT5;CABIN1;SAG;LMTK2;STYXL1;BOD1L1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3911072943010542,0.8594337219044745,0.6185344827586207,0.8468843969918681,1.0,2/13,8.23%,SREBF2;ECI1
prerank,histone methyltransferase activity (GO:0042054),-0.2937994890060307,-0.8531219974995805,0.6943866943866944,0.9315487355409595,1.0,5/32,10.03%,SMYD3;SETD7;KMT5A;CARM1;EHMT1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4187861609367177,0.8500710046888635,0.6122881355932204,0.8601399856646625,1.0,2/10,6.31%,OTUD5;DESI2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.3688815296274629,-0.848588680492781,0.655367231638418,0.9367362674295905,1.0,5/12,20.22%,MTPAP;TENT5A;PAPOLB;TENT5C;TENT4B
prerank,ribosome binding (GO:0043022),0.3151428928043537,0.8484501552001381,0.6349206349206349,0.859748985309675,1.0,17/46,21.58%,CPEB1;MRPS27;YTHDF3;SRP72;EIF3C;NCLN;EIF6;GTPBP6;CPEB4;C1QBP;FMR1;NAA15;OXA1L;EEF2;SEC61A2;SRP68;EIF2S1
prerank,anion:anion antiporter activity (GO:0015301),-0.32492844441397406,-0.8468410690122551,0.6828358208955224,0.9366131479269079,1.0,3/17,8.77%,SLC26A7;SLC26A2;SLC25A4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.34823077264861596,0.844561274974349,0.6161417322834646,0.8631624676399162,1.0,6/21,17.93%,CHRNA3;CHRNA7;GRIK2;CHRNB2;P2RX5;GLRB
prerank,methyl-CpG binding (GO:0008327),0.3579499655287088,0.8439774914738475,0.5878787878787879,0.8608876348399601,1.0,4/22,10.73%,CDX1;MECP2;LHX4;PRMT1
prerank,motor activity (GO:0003774),0.29937525900733486,0.8431692072561545,0.6605042016806723,0.8590074670479592,1.0,14/60,15.94%,STARD9;MYH9;KIF26B;MYO6;DYNC1I2;KIF3A;KIF20A;KIF5C;KIF3C;APPBP2;KIF21A;KIFC2;KIF6;KIF7
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.37876055226933225,0.8428645428426913,0.6265306122448979,0.8562202348851511,1.0,1/14,1.67%,RDH5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.24473647665332646,0.8416408350023961,0.7725490196078432,0.8549876535822006,1.0,25/248,8.86%,RASL12;RERG;MYH9;RND3;AGAP2;GNAZ;RAB8B;ABCD2;TOR1B;RAC3;ATAD1;RIT2;DNAJC27;RAB3B;DDX3X;TPPP;RAP1A;HRAS;GNG5;RAB28;ARHGDIB;MYO6;RAB38;GNA12;RNF112
prerank,CXCR chemokine receptor binding (GO:0045236),0.3961299128595429,0.8397398022372068,0.6252723311546841,0.8550589650292504,1.0,3/11,12.77%,CXCL10;CXCL5;YARS1
prerank,phosphate ion binding (GO:0042301),0.4062655932616988,0.8389094776165877,0.6013363028953229,0.8533684993279378,1.0,2/10,7.42%,RPH3A;MTHFD2
prerank,ribonuclease activity (GO:0004540),-0.2615287944981942,-0.8387073747860537,0.7250608272506083,0.9487570737470006,1.0,14/56,20.39%,CNOT7;RNASE4;NYNRIN;SMG6;SAMHD1;ZC3H12A;ERN1;INTS11;EXOSC5;RNASEL;ELAC2;RNASE12;AGO1;DICER1
prerank,cytokine receptor activity (GO:0004896),0.2786869535050036,0.8386913734691976,0.6815181518151815,0.8504628673764987,1.0,10/83,8.74%,IL15RA;IL1RL2;IL17RD;GFRA2;CCRL2;IL2RA;IL12RB1;ACKR2;CCR9;OSMR
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3645088975764523,-0.8382750013711913,0.6697588126159555,0.9459859764445603,1.0,6/11,26.83%,APEX2;NEIL3;RPS3;NEIL1;APLF;NTHL1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.37726816841352084,-0.8365578516834032,0.6795366795366795,0.9455963544694329,1.0,1/10,0.43%,DPYSL3
prerank,chemoattractant activity (GO:0042056),-0.3024939030575096,-0.8342763251702285,0.7061224489795919,0.9465903391553877,1.0,4/26,6.31%,BMP4;VEGFD;VEGFC;CCL15
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.20218674557552413,-0.8331330724750826,0.9369747899159664,0.9451172840669995,1.0,95/269,28.98%,SNCAIP;SMAD3;EGFR;SMAD6;FOXO1;FHIT;SNX9;SMAD7;SKI;PARP9;ARRB1;STAT2;TNFRSF1B;IKBKE;TXNIP;MFHAS1;STAT1;HSPA5;ACTG1;POLR2A;FZD4;DTX3L;HGS;TRIOBP;HIF1A;PCBP2;BECN1;CASP8;ARRDC1;PML;PATZ1;RPL11;CUL4A;MDM2;RELA;SLC22A18;UBB;CALR;PRKACB;ELOB;TUBA1B;HSP90AB1;NEDD8;WASHC1;DTX1;FZD8;RPL23;TMBIM6;CBS;RNF40;SMG5;RIPK1;GABARAPL1;NFKBIA;ERLIN2;EIF4E2;NPLOC4;TRIB1;PPARGC1A;VCP;PIAS4;IKBKG;CDK5RAP3;UBE2L6;RFFL;UBXN1;CUL5;WRAP53;HSPA9;USP2;CHEK2;RNF8;BRCA1;YWHAE;PRKN;TRIP4;TP53;BAG5;KCNH2;SCAMP3;BCL10;ATXN3;FZD5;PRR7;TRIB3;HSPA1B;CLU;SLF1;ATP6V0C;TNK2;LAPTM5;BAG1;SMAD2;ISG15;JUN
prerank,RNA stem-loop binding (GO:0035613),-0.370765682577865,-0.832382090100626,0.698292220113852,0.9430388760037458,1.0,4/12,12.44%,RC3H2;MYH10;ZC3H12A;CPEB3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.39136506874417504,0.8300208111792629,0.6121593291404612,0.8623611594635623,1.0,3/11,12.99%,PRMT1;PRMT3;PRMT7
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3293208941208852,-0.828919726606033,0.696078431372549,0.9458417952146525,1.0,5/16,17.21%,SLC22A4;SLC25A17;SLC22A5;SLC22A2;SLC25A26
prerank,Toll-like receptor binding (GO:0035325),-0.3633209117652151,-0.828366285457431,0.7189922480620154,0.9432284272927273,1.0,7/11,43.79%,DAB2IP;MYD88;CD36;TLR6;TLR1;TLR2;S100A9
prerank,hexosaminidase activity (GO:0015929),0.3881818101894133,0.8264801119188881,0.6210526315789474,0.865508962917793,1.0,2/12,2.63%,CEMIP2;HYAL4
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.384912716910366,0.8257591917536904,0.6389496717724289,0.8635584307612325,1.0,3/10,8.59%,HEXIM1;CDKN1A;INCA1
prerank,deubiquitinase activity (GO:0101005),-0.23134369293441792,-0.8252826517678212,0.8259668508287292,0.9451848046407166,1.0,15/88,13.63%,USP53;USP47;USP46;USP12;USP8;USP15;USP18;USP34;ZC3H12A;USP35;USP11;USP5;MINDY1;USP49;MPND
prerank,hormone activity (GO:0005179),-0.25007876922677236,-0.8193166085845623,0.769041769041769,0.9525526967134338,1.0,10/54,23.79%,IGF1;METRNL;CCL25;PTHLH;EDN3;AGT;PPY;GNRH1;AGRP;PENK
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3353401959409237,0.8188537384779884,0.6513026052104208,0.8721588852366249,1.0,6/24,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC17;ZDHHC21;ZDHHC23
prerank,water transmembrane transporter activity (GO:0005372),-0.36247718051363437,-0.818665909432051,0.7217068645640075,0.9500898620034343,1.0,1/11,1.41%,PDPN
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.31909428437059845,0.8141360794835829,0.6692456479690522,0.8770208140632775,1.0,7/31,10.87%,UBE2QL1;UBE2E3;UBE2J2;UBE2E1;UBE2G1;BIRC6;AKTIP
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.40479319110382206,0.8111854175904684,0.6316916488222698,0.8787284173483991,1.0,3/10,17.43%,DCLRE1B;TATDN1;APEX1
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.23002196241105083,-0.810189038146841,0.8404255319148937,0.9615885995694491,1.0,14/83,13.63%,USP53;USP47;USP46;USP12;USP8;USP15;USP18;USP34;ZC3H12A;USP35;USP11;USP5;USP49;MPND
prerank,channel activity (GO:0015267),-0.2651938670664544,-0.8099419092558926,0.8037974683544303,0.9584000633508504,1.0,7/41,15.56%,PDPN;MCUB;TRPV4;MPV17;TMEM120B;CHRNB1;AQP11
prerank,hormone receptor binding (GO:0051427),0.36487423450910883,0.8073742340642373,0.6546610169491526,0.8821747519226971,1.0,3/14,7.65%,JAK1;CCK;NCOA6
prerank,microtubule motor activity (GO:0003777),0.2916375455147629,0.8005896636653097,0.7089285714285715,0.8902050983926332,1.0,12/51,15.94%,STARD9;KIF26B;DYNC1I2;KIF3A;KIF20A;KIF5C;KIF3C;APPBP2;KIF21A;KIFC2;KIF6;KIF7
prerank,mRNA 3'-UTR binding (GO:0003730),-0.2301520926667956,-0.7997631126257451,0.8756345177664975,0.9729080121560237,1.0,21/79,19.28%,CELF2;RBMS2;LARP4B;DDX5;RPL41;CPEB2;IGF2BP2;ZC3H12A;PUM1;CPEB3;YBX3;LARP1;AUH;GEMIN5;FXR2;ELAVL1;RNF40;RPS7;CSDC2;ZFP36L2;PABPC4L
prerank,alkali metal ion binding (GO:0031420),0.3692330110516305,0.7993116164515287,0.6723404255319149,0.8891127187558142,1.0,1/13,1.22%,ATP1A2
prerank,phosphatidate phosphatase activity (GO:0008195),-0.3356012928903434,-0.7986918369843927,0.7294117647058823,0.9711429856622119,1.0,6/13,27.19%,PLPP3;PLPP1;LPIN3;PLPP4;PLPPR4;PLPP2
prerank,glutathione transferase activity (GO:0004364),-0.2941988819061697,-0.7980686081525912,0.7484662576687117,0.9685950469579326,1.0,5/23,14.24%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2
prerank,N-acetyltransferase activity (GO:0008080),-0.3102336872167149,-0.7944644228815614,0.7616387337057728,0.9709471117067892,1.0,11/19,44.91%,KAT2B;NAT10;SAT1;NAA80;NAT2;NAT14;NAA10;AANAT;NAT8;NAT1;SMARCE1
prerank,phosphatase activator activity (GO:0019211),-0.3332581486494962,-0.7942958334202219,0.7471264367816092,0.9676900236932677,1.0,4/14,18.59%,CALM2;FRS2;CALM1;PPP2R5C
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3362227410867461,-0.7919519152616202,0.7751371115173674,0.9680315429891497,1.0,3/12,11.28%,SLC6A6;SLC38A5;SLC3A2
prerank,deoxyribonuclease activity (GO:0004536),-0.3261848548138232,-0.7897971451847469,0.7514910536779325,0.9678846817463359,1.0,6/14,26.31%,ERCC5;DNASE1L1;NME1;DFFB;RPS3;APLF
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.35806898631052586,0.788721549491169,0.68762278978389,0.9037553131028965,1.0,2/14,4.36%,BLVRB;DHFR
prerank,signaling receptor complex adaptor activity (GO:0030159),0.30711229667327467,0.787543724511771,0.7030651340996169,0.9023894974529632,1.0,4/38,3.58%,PIK3R1;NCK2;LDLRAP1;SH2B3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.27171714562040206,-0.7866562597169674,0.7867494824016563,0.9692180638207758,1.0,4/30,7.95%,CAST;GAS6;BIRC3;CST3
prerank,receptor tyrosine kinase binding (GO:0030971),0.2827562689433109,0.7861154468305722,0.746031746031746,0.9015647554847366,1.0,10/56,11.02%,PIK3R1;NRG1;SH2B3;NRG3;PITPNM2;SOCS5;IRS1;SHC4;BLNK;CBLB
prerank,retinoid X receptor binding (GO:0046965),0.369062338340043,0.7836897798409359,0.6884531590413944,0.9022559120720105,1.0,3/11,7.65%,TACC1;ARID5A;NCOA6
prerank,enoyl-CoA hydratase activity (GO:0004300),0.37191188926476404,0.7821922237310195,0.6717724288840262,0.9014747304102829,1.0,2/10,8.23%,HADHB;ECI1
prerank,phospholipase A2 activity (GO:0004623),-0.2769662602444588,-0.7785058972616953,0.7870182555780934,0.9791002972477924,1.0,3/26,13.21%,PLA2G4A;PLA2G6;PLA2G15
prerank,CoA-ligase activity (GO:0016405),-0.31604812424669276,-0.7775438422449619,0.755877034358047,0.9770077848111264,1.0,1/14,2.17%,ACSS3
prerank,transcription corepressor binding (GO:0001222),0.31137155223099994,0.7769866495663589,0.7340823970037453,0.9067230181444458,1.0,3/27,5.75%,RORA;PER2;CNOT2
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.24285830722016027,-0.7749100790834834,0.8587962962962963,0.9774345319439195,1.0,14/49,17.09%,MPPED2;PTPRJ;DUSP12;PPP1CB;SAMHD1;DUSP16;PXYLP1;EPHX2;PGAM5;PGP;SMPDL3A;DUSP10;DUSP23;LHPP
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3272990153345722,-0.7700386052301089,0.7844311377245509,0.981315852908319,1.0,1/13,2.48%,AGPAT4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.31666667289295847,-0.769359937102668,0.7565392354124748,0.9789156253773476,1.0,8/16,40.14%,PIR;ALOX12;CDO1;HGD;ALOXE3;HAAO;ALOX5;ADI1
prerank,receptor antagonist activity (GO:0048019),-0.3094591184726,-0.7692381046308704,0.7657142857142857,0.9756030839810863,1.0,1/17,1.79%,DKK3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.2222060793316577,-0.7679688576973303,0.9133663366336634,0.9739053923746588,1.0,12/75,16.59%,ABCC4;DHRS3;CRYL1;SORD;ME1;DHDH;BDH1;PGD;ADH1A;BDH2;AKR1A1;HSD17B7
prerank,solute:sodium symporter activity (GO:0015370),-0.2734252103508248,-0.7677589997025257,0.8041237113402062,0.9708373473026771,1.0,3/27,9.26%,SLC4A10;SLC20A2;SLC5A6
prerank,lipid phosphatase activity (GO:0042577),-0.31829760179044064,-0.7675100542257237,0.779385171790235,0.9678165318403601,1.0,6/14,27.19%,PLPP3;PLPP1;EPHX2;INPP5K;PLPPR4;PLPP2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.28828569067957893,-0.7650878676239479,0.7906976744186046,0.9679262640133038,1.0,12/20,40.85%,SETD7;KMT5A;EHMT1;ETFBKMT;SETD6;SETD4;EEF1AKMT3;EEF2KMT;METTL21C;VCPKMT;EEF1AKMT4;SMYD2
prerank,NF-kappaB binding (GO:0051059),-0.28062564359314873,-0.7649595016227169,0.7729083665338645,0.964734729108998,1.0,7/24,22.85%,ANXA4;HDAC1;RELA;TAF4B;NFKBIA;CDK5RAP3;SETD6
prerank,DNA replication origin binding (GO:0003688),0.3137542008776114,0.7643996876799175,0.7373358348968105,0.9239526085053446,1.0,6/23,17.60%,KAT7;MCM6;MCM7;MCM2;ORC4;DDX11
prerank,exonuclease activity (GO:0004527),-0.24098054903528365,-0.7643724719029642,0.8538283062645011,0.9623290130840504,1.0,10/46,15.38%,ENPP1;CNOT7;ENPP3;DCLRE1C;REXO4;ZC3H12A;APEX2;ISG20L2;RAD50;EXOSC5
prerank,ubiquitin-protein transferase activity (GO:0004842),0.21478513812297345,0.7642270061022085,0.9315068493150684,0.9209219269960619,1.0,67/346,16.36%,NEDD4L;TNFAIP1;DTX3;UBR1;HECW2;BTRC;TRIM9;RNF150;CUL3;RBX1;TRAF5;PELI2;SIAH2;MYLIP;TRIM43;TRIM62;UBE2QL1;CBLL1;UBE2E3;NEURL3;NEURL1B;RCHY1;UBR3;HACE1;UBE2J2;TRAF3;VPS18;UBE2E1;SIAH3;MIB2;RNF25;KCTD13;FBXO24;RNF112;HECW1;UBE2G1;BIRC6;VPS11;RLIM;TSPAN17;CNOT4;AKTIP;CBLB;TRIM2;PPIL2;UBE3A;UBR2;RNF121;PPP1R11;RNF114;TRAF6;RMND5B;TRAF2;KLHL13;TRIM45;LMO7;ARIH1;ZFP91;RNF103-CHMP3;PEX12;RNF138;ZNRF2;TRIM37;ERCC8;NFX1;RNF6;RNF166
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.29539879708696465,0.7633058411034149,0.7467166979362101,0.9192526504890631,1.0,9/33,14.06%,NCOA3;CCAR2;TBP;RPRD1B;DRAP1;CTR9;HNRNPU;URI1;UVSSA
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2936833450718594,0.7631604149006166,0.7317073170731707,0.9163029112910768,1.0,7/34,10.87%,UBE2QL1;UBE2E3;UBE2J2;UBE2E1;UBE2G1;BIRC6;AKTIP
prerank,N-methyltransferase activity (GO:0008170),0.3172116591576488,0.760423751458282,0.7433264887063655,0.9171904335964357,1.0,9/20,22.52%,TRMT1;RNMT;TRMT11;PRMT1;SETD3;METTL18;TFB2M;TRMT1L;DIMT1
prerank,four-way junction DNA binding (GO:0000400),-0.29990124693364373,-0.7584951190138219,0.8042226487523992,0.9671583275662636,1.0,11/17,44.17%,RAD51B;HMGB2;RAD51C;MSH6;FANCM;ABL1;WRN;RAD51D;HMGB3;GEN1;YY1
prerank,phosphotyrosine residue binding (GO:0001784),0.2886632623058486,0.7572565122859286,0.7675675675675676,0.9186688254919755,1.0,3/37,2.26%,PIK3R1;NCK2;LDLRAP1
prerank,damaged DNA binding (GO:0003684),0.27857434848697754,0.7551350501557635,0.7613240418118467,0.9186807258053729,1.0,17/44,23.22%,DCLRE1B;FANCG;ERCC4;RAD1;AUNIP;EP300;XPC;SMC6;RPA2;APEX1;SDE2;DDB2;MPG;CREBBP;XRCC1;PNKP;RAD18
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2549314637901149,-0.7528258963229599,0.8534653465346534,0.9721178944699994,1.0,19/34,40.85%,SMYD3;SETD7;KMT5A;EHMT1;EZH2;SETDB1;ETFBKMT;SETD6;SETD4;CAMKMT;DOT1L;EEF1AKMT3;EEF2KMT;METTL21C;KMT2E;VCPKMT;EEF1AKMT4;N6AMT1;SMYD2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.32657789221039424,0.7509687156306519,0.7242152466367713,0.9218471537956605,1.0,7/15,22.43%,KMT2B;SETMAR;SETD3;KMT2A;KMT2D;WDR5;SETD1A
prerank,epidermal growth factor receptor binding (GO:0005154),-0.27032654439640164,-0.750808306479486,0.8143712574850299,0.9715418979189153,1.0,2/25,1.69%,EFEMP1;TGFA
prerank,acid-thiol ligase activity (GO:0016878),-0.3137668397772545,-0.7483296454684102,0.7963302752293578,0.9713807740812992,1.0,1/13,2.17%,ACSS3
prerank,RNA cap binding (GO:0000339),-0.30032173181552524,-0.748185698440367,0.7931034482758621,0.9682891459069174,1.0,5/16,18.29%,CYFIP2;EIF4A1;LARP1;GEMIN5;EIF4E2
prerank,1-phosphatidylinositol binding (GO:0005545),0.34237706424467385,0.7480378581277759,0.696652719665272,0.9232158458633635,1.0,3/15,5.89%,SCARB1;EPB41;WDFY3
prerank,ATPase regulator activity (GO:0060590),-0.2518364821826665,-0.7477824958610944,0.8430493273542601,0.9655836186944493,1.0,12/38,22.02%,ATP1B3;FNIP1;BAG3;TOR1AIP1;DNAJB2;DNAJC24;PFN1;DNAJB6;DNAJC15;DNAJC10;BAG2;PLN
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3340993448896831,-0.746413417852118,0.7876447876447876,0.9641238573667519,1.0,1/10,1.07%,B4GALT1
prerank,ubiquitin protein ligase binding (GO:0031625),0.21865132633467224,0.7447164683183038,0.9312169312169312,0.9249004612127727,1.0,38/254,12.06%,GLMN;VCL;FZD6;USP25;PRR5L;PTPN22;CUL3;RBX1;ABI2;TRAF5;JAK1;TRIB2;FAF2;SCN5A;MAGEC2;UCHL1;SPOPL;PRKAR2B;YWHAZ;UBE2J2;TRAF3;BLZF1;CDKN1A;GPR37;PRKAR2A;SLF2;UBE2G1;DET1;NKD2;NEK6;PRKAR1A;OTUB1;AXIN2;RB1;GPI;NLK;APC;SPOP
prerank,endopeptidase activator activity (GO:0061133),-0.3330284482461444,-0.7443659101612901,0.8061594202898551,0.9636803756528761,1.0,6/10,43.85%,PSME2;PSME3;VSIR;APH1A;PSENEN;PSMD14
prerank,Notch binding (GO:0005112),0.3066232212589598,0.7429966148644025,0.7673956262425448,0.9242683626546997,1.0,4/22,4.35%,DLL3;CHAC1;CUL3;DNER
prerank,Hsp90 protein binding (GO:0051879),0.29152296771754344,0.7416969944130223,0.7701375245579568,0.9230331330590351,1.0,1/33,0.64%,SLC12A2
prerank,vitamin D receptor binding (GO:0042809),0.32929828582683635,0.7391688815964121,0.7362869198312236,0.9233390759142694,1.0,9/14,28.56%,MED13;MED1;MED4;MED30;MED16;TAF7;MED14;SNW1;MED17
prerank,kinase inhibitor activity (GO:0019210),0.29255056903632215,0.7365158743116513,0.7852998065764023,0.9239799093673243,1.0,6/33,10.76%,SPRY4;HEXIM1;SNCA;TAOK3;CDKN1A;PRKRIP1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.27364113646390603,-0.7350861479127931,0.8323471400394478,0.9721048572101029,1.0,4/22,12.62%,APOE;HSPG2;MESD;AP2A1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.32600029272588854,0.734126862531584,0.7424547283702213,0.9245268591600497,1.0,4/17,10.72%,BAAT;ACOT12;PPT1;ACOT2
prerank,histone methyltransferase binding (GO:1990226),-0.3249407669938552,-0.732921476119209,0.7996031746031746,0.971471688723412,1.0,1/11,1.65%,LCOR
prerank,single-stranded DNA helicase activity (GO:0017116),0.3204394164480881,0.7310790042755132,0.7709611451942741,0.9255928885398399,1.0,5/19,16.87%,MCM6;WRNIP1;MCM7;MCM2;PIF1
prerank,adenylyltransferase activity (GO:0070566),-0.2779754205244392,-0.7300733310169424,0.814176245210728,0.9717757999869446,1.0,10/21,32.79%,OAS2;KARS1;MTPAP;NMNAT1;PAPOLB;TENT4B;ABL1;OASL;GPHN;FICD
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2702907411716719,-0.7274990493984845,0.8700440528634361,0.9718568069690348,1.0,8/22,36.95%,IKBKE;OPTN;WDR81;IKBKG;MINDY2;PARP10;TAB2;ZRANB3
prerank,GABA receptor binding (GO:0050811),0.34149772645740617,0.7260087175889943,0.7505422993492408,0.9293775274109756,1.0,6/11,22.03%,PLCL2;TRAK1;TRAK2;JAKMIP1;GABARAP;GABARAPL2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3383968363567887,0.7256966660859046,0.7516059957173448,0.9267631773267069,1.0,11/11,66.18%,HCN2;CNGB1;HCN1;CNGA1;KCNA10;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4
prerank,protein phosphorylated amino acid binding (GO:0045309),0.27300881443989966,0.7247132597194481,0.8163992869875223,0.9250466970927411,1.0,3/42,2.26%,PIK3R1;NCK2;LDLRAP1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2732499813680167,-0.722462964864277,0.8402255639097744,0.9748754209663602,1.0,3/21,9.31%,FGF1;KL;FRS2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.3232415720640354,0.7141315276646392,0.7604395604395604,0.9361300780679446,1.0,4/12,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.33252978520360665,0.7126858587301712,0.7797979797979798,0.9350992797635439,1.0,3/10,17.44%,NAA11;NAA30;NAA15
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.28008408477090363,-0.7113808468773797,0.85451197053407,0.9846480213440483,1.0,6/17,24.76%,LBR;DPYD;BDH2;DECR1;PTGR2;PTGR1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.25120534001263806,-0.7082083076478294,0.8747474747474747,0.9851898809908705,1.0,4/27,12.62%,APOE;HSPG2;MESD;AP2A1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.287693584778565,-0.7072147148593926,0.8395303326810176,0.9831582852479658,1.0,1/15,2.48%,AGPAT4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.2774895999062919,0.7062045115508897,0.8122676579925651,0.9403148268290258,1.0,9/33,17.12%,NCOA3;CCAR2;RPRD1B;CTR9;MAF1;HNRNPU;URI1;UVSSA;RRN3
prerank,chemokine receptor binding (GO:0042379),-0.23496266449994896,-0.6986664991795799,0.9030927835051547,0.9891318000059798,1.0,21/35,43.90%,CXCL12;CCL15;CCL14;CCL25;CXCL16;CCL13;CCL19;CKLF;CCL2;ITCH;CX3CL1;CCL28;CCL5;CCL11;CX3CR1;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.29838743503770265,-0.6982373780504757,0.8407407407407408,0.9863607818251716,1.0,4/12,18.29%,CYFIP2;LARP1;GEMIN5;EIF4E2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2959599787613172,-0.6969279992200458,0.8336520076481836,0.9844926053802067,1.0,7/13,45.54%,DNASE1L1;DICER1;SLX4;EXO1;FEN1;GEN1;FAN1
prerank,MHC protein binding (GO:0042287),-0.2620609987487873,-0.6967283369845404,0.8814531548757171,0.9814980194711376,1.0,6/20,28.09%,TAPBP;CD81;TUBB4B;TAP2;LAG3;TAP1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.28946958839416265,0.6966293742648739,0.8159392789373814,0.9431526918391752,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,serotonin receptor activity (GO:0099589),0.28946958839416265,0.6966293742648739,0.8159392789373814,0.9431526918391752,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.28946958839416265,0.6966293742648739,0.8159392789373814,0.9431526918391752,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,RNA polymerase binding (GO:0070063),0.2994759436772135,0.6962076527077558,0.8221343873517787,0.9405986028732758,1.0,4/18,11.56%,PHRF1;BIN1;TCERG1;YTHDC2
prerank,endonuclease activity (GO:0004519),-0.2186485442383283,-0.6930723526548795,0.9623059866962306,0.9818964257321492,1.0,18/49,29.58%,N4BP2;NYNRIN;ERCC5;SMG6;REXO4;ZC3H12A;ERN1;INTS11;RNASEL;AGO1;DICER1;RPS3;ZC3H12B;APLF;RNASEK;NTHL1;AGO2;ENDOU
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2384194138714387,0.6927814133629319,0.9052969502407705,0.9416911807451815,1.0,20/69,19.01%,ZDHHC14;BAAT;PLAAT1;ZDHHC1;ZDHHC2;CERS4;ZDHHC16;PLA2G4E;KAT6A;GLYAT;EP300;ZDHHC17;ZDHHC21;HHAT;AWAT2;NAA15;ZDHHC9;SOAT2;CERS6;CERS5
prerank,ligand-gated calcium channel activity (GO:0099604),0.2993988996111765,0.6921007908018775,0.7917485265225933,0.9395168161423462,1.0,6/19,15.86%,ITPR1;RYR2;RYR3;GRIN2B;RASA3;GRIN2A
prerank,endoribonuclease activity (GO:0004521),-0.23836544776728816,-0.6881650770271571,0.9131313131313131,0.9834166487074567,1.0,17/32,37.99%,NYNRIN;SMG6;ZC3H12A;ERN1;INTS11;RNASEL;AGO1;DICER1;ZC3H12B;RNASEK;AGO2;ENDOU;EXOG;ENDOG;RIDA;CPSF3;ZC3H12D
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.32457454751484466,0.6802757635380403,0.7835497835497836,0.9507845005664728,1.0,4/10,18.20%,FUOM;RPE;GALE;GALM
prerank,miRNA binding (GO:0035198),-0.23251020625629676,-0.6794308641686376,0.8853118712273642,0.9888752773459025,1.0,8/30,19.18%,TUT4;TUT7;ZC3H12A;RBM10;PUM1;ELAVL1;PNPT1;AGO1
prerank,RNA polymerase II complex binding (GO:0000993),0.2648677985304092,0.6757510365676267,0.8606403013182674,0.9530605534766817,1.0,7/32,14.06%,NCOA3;CCAR2;RPRD1B;CTR9;HNRNPU;URI1;UVSSA
prerank,3'-5' DNA helicase activity (GO:0043138),-0.27063592479938214,-0.6737225192560108,0.8732943469785575,0.990869879798701,1.0,9/16,34.90%,ASCC3;NAV2;RECQL;ERCC3;FANCM;WRN;MCM5;HELQ;RECQL5
prerank,CoA hydrolase activity (GO:0016289),0.30068787462188873,0.6688076272258459,0.8045267489711934,0.9577069987548378,1.0,4/16,15.91%,BAAT;ACOT12;ACOT2;ACOT7
prerank,ion channel inhibitor activity (GO:0008200),0.2604429405715509,0.6686241543184432,0.8679245283018868,0.9548105622473796,1.0,2/35,3.94%,NEDD4L;ITPR1
prerank,protein phosphatase regulator activity (GO:0019888),0.24608880785363318,0.6679682391699032,0.8940972222222222,0.9525536647679009,1.0,18/53,22.02%,PTN;PPP2R2A;ANKLE2;PPP1R16A;PPP2R5D;SET;PPP6R2;PPP4R4;MGAT5;CABIN1;SAG;PPP1R15A;PPP2R1A;PPP2R5B;LMTK2;CALM3;STYXL1;BOD1L1
prerank,Hsp70 protein binding (GO:0030544),-0.23076145135176346,-0.6663245073794535,0.9342105263157895,0.9945307229194132,1.0,13/31,28.50%,HDAC8;ERN1;DNAJB2;PPEF2;PPID;DNAJC10;DNAJB12;RPS3;DNAJC2;DNAJC8;PRKN;IQCG;MVD
prerank,hydro-lyase activity (GO:0016836),0.24769732630243005,0.6643655814788686,0.8927272727272727,0.953358603270499,1.0,5/41,8.23%,CA4;ACO2;HADHB;ALAD;ECI1
prerank,myosin V binding (GO:0031489),0.2922036767491452,0.6617730238285948,0.8476394849785408,0.9530199977805951,1.0,2/15,6.01%,RAB39B;RAB3B
prerank,methyltransferase activity (GO:0008168),0.2430771310382604,0.6592801674308654,0.8876611418047882,0.9525192728221367,1.0,12/46,17.91%,NSUN3;AS3MT;TRMT11;EEF1AKMT1;PRMT1;GCSH;PRMT3;PRMT7;SUV39H1;GAMT;METTL4;NSUN2
prerank,solute:proton symporter activity (GO:0015295),-0.2641992201476374,-0.6523215951685435,0.912621359223301,1.0,1.0,2/16,10.60%,SLC2A13;SLC39A8
prerank,tRNA binding (GO:0000049),-0.20730761201762316,-0.6500260215394117,0.9622222222222222,1.0,1.0,10/43,19.41%,EEF1A1;KARS1;CARS1;ELP1;SARS1;XPOT;TYW5;TRNAU1AP;TRMT10B;NAT10
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.2123616224024976,-0.6490492552844696,0.9502164502164502,0.9993027497262469,1.0,11/34,26.40%,CNOT7;NOCT;ERI3;CNOT8;EXOSC5;PNPT1;TOE1;PNLDC1;PAN3;EXOSC7;ANGEL2
prerank,single-stranded DNA binding (GO:0003697),-0.1811204506070673,-0.6486588479346078,0.9941348973607038,0.9964658283866911,1.0,24/93,24.60%,SSBP2;SSBP1;RAD51B;RTF1;ERCC5;REXO4;PCBP2;SAMHD1;BRCA2;NABP1;RPA1;HMGB2;PARK7;MCMDC2;RAD52;TOP3A;NEIL3;MCM8;WBP11;RAD51;CDC45;ERCC1;RPA3;POLR2G
prerank,growth factor activity (GO:0008083),0.21877430079650556,0.6477933961505493,0.9449225473321858,0.9609797227649222,1.0,8/74,9.27%,PTN;NRG1;NRG3;FGF2;IL4;FGF10;PDGFB;JAG1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.2943523692423723,0.6469130631398821,0.8372093023255814,0.9589198932256885,1.0,4/14,15.62%,AK8;AK7;AK5;AK4
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3085560351484467,0.6449260468562124,0.8211920529801324,0.9579527793890706,1.0,4/11,20.71%,RBX1;PPIL2;STUB1;UBE4A
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.23495651859565375,-0.6434784454739048,0.9298969072164949,0.9972732425258968,1.0,6/26,20.64%,CSGALNACT1;CHSY1;B3GALNT1;EXTL2;CHPF2;B3GALNT2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2667642792604472,0.6419128269602653,0.862,0.9580032853668679,1.0,6/24,15.63%,ITPKB;AK8;AK7;AK5;AK4;AK3
prerank,glycine binding (GO:0016594),0.30313662699632105,0.640790085404183,0.8410596026490066,0.9562217984557737,1.0,4/11,21.35%,GRIN2B;SRR;GLRB;GRIN1
prerank,MHC class I protein binding (GO:0042288),-0.26584383198967076,-0.6358521727629517,0.8990654205607477,0.9997099428590591,1.0,4/13,28.09%,TAPBP;TUBB4B;TAP2;TAP1
prerank,ribonuclease P activity (GO:0004526),-0.27339677991214145,-0.6333185242875482,0.8926553672316384,0.9984089389064138,1.0,5/11,37.74%,PRORP;RPP38;POP1;RPP21;RPP40
prerank,dynactin binding (GO:0034452),0.2972880376945052,0.6322094932621227,0.8586723768736617,0.961260038098837,1.0,4/12,18.00%,HOOK3;BICD2;HTT;GSK3B
prerank,NADPH binding (GO:0070402),-0.26115606538158337,-0.6299628377604172,0.9239766081871345,0.9977066078704901,1.0,4/13,27.29%,LBR;DECR1;GRHPR;MTRR
prerank,tRNA methyltransferase activity (GO:0008175),0.28207226244829475,0.6268523399701668,0.8642241379310345,0.9633598409596469,1.0,2/16,9.71%,TRMT5;THUMPD2
prerank,neuropeptide binding (GO:0042923),0.2701067280322822,0.625637363051659,0.8830409356725146,0.9615666650109403,1.0,2/18,8.13%,OPRK1;GPR37
prerank,telomeric DNA binding (GO:0042162),-0.21450128652418676,-0.623116954465661,0.959915611814346,0.9991348137498652,1.0,7/32,22.33%,SMG6;UPF3A;RPA1;RAD50;SMG5;UPF2;ACD
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2369557646107578,-0.6219797918459216,0.9292929292929293,0.9968008030602494,1.0,11/20,36.99%,ERCC5;DCLRE1C;RAD50;ERCC1;RPS3;APLF;EXO1;EXOG;ENDOG;ZRANB3;FEN1
prerank,pyridoxal phosphate binding (GO:0030170),-0.23866651943589218,-0.621702308151521,0.9432048681541582,0.9938959294172084,1.0,10/20,33.11%,PYGB;OAT;CBS;AGXT;ABAT;PDXK;PNPO;PYGL;GLDC;SHMT1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.25665892584274785,-0.6199325287069949,0.9273084479371316,0.9919422505692727,1.0,6/14,25.46%,ACO1;ISCA2;RSAD2;EXO5;NDUFS1;SDHB
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.28080812525231,0.6197553838997972,0.8518518518518519,0.9636410289913877,1.0,2/14,6.31%,OTUD5;DESI2
prerank,ribosomal small subunit binding (GO:0043024),-0.2427569048274575,-0.6145559895626166,0.9119373776908023,0.992339864566578,1.0,5/17,19.05%,CPEB2;MTIF3;NME1;LARP1;EIF1B
prerank,regulatory RNA binding (GO:0061980),-0.19802718046088025,-0.6063455255558727,0.9624217118997912,0.9940815927961498,1.0,9/38,20.39%,TUT4;TUT7;ZC3H12A;RBM10;PUM1;ELAVL1;PNPT1;AGO1;DICER1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.2584784633725632,-0.6056020631408856,0.9258555133079848,0.9915381186808179,1.0,1/11,6.45%,DDAH1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.2873140169503414,0.6042755682370935,0.8838709677419355,0.9734008814544832,1.0,3/11,13.88%,RDH14;DHRS13;RDH12
prerank,single-stranded telomeric DNA binding (GO:0043047),0.28930754230522027,0.598768505267981,0.8742004264392325,0.9746356672447746,1.0,5/11,22.11%,HNRNPA1;RPA2;TERF1;HNRNPA2B1;CTC1
prerank,CCR chemokine receptor binding (GO:0048020),-0.20755567444569786,-0.5893189966478974,0.9657258064516129,0.9971588545631341,1.0,21/28,52.70%,CCL15;CCL14;CCL25;CCL13;CCL19;CCR2;CCL2;NARS1;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.19910371147762965,-0.586112066989153,0.9730848861283644,0.9958089537343534,1.0,9/35,23.96%,MTFMT;TARS2;FTO;ELAC2;TRIT1;PTRH2;TRMT13;FTSJ1;TRMT12
prerank,carboxy-lyase activity (GO:0016831),-0.21438145589218405,-0.5773155707699644,0.9653767820773931,0.9971183259788708,1.0,5/23,22.15%,CSAD;ODC1;DDC;BCKDHA;AZIN1
prerank,RNA methyltransferase activity (GO:0008173),0.2495907399286836,0.5764142453760884,0.9260780287474333,0.9871630454962993,1.0,2/19,6.05%,FBLL1;TRMT5
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.22946431568511724,0.5759180291742545,0.928709055876686,0.9844585243254376,1.0,8/27,19.09%,POLR2C;POLR3H;MED20;POLR1A;PRIM1;POLR1B;POLR3F;POLR2D
prerank,nuclear import signal receptor activity (GO:0061608),0.2591880758536335,0.5742487591658426,0.9147609147609148,0.982562607009808,1.0,4/15,20.98%,KPNA4;KPNA1;TNPO1;KPNA3
prerank,carbohydrate kinase activity (GO:0019200),-0.2510295456366361,-0.5729655279391186,0.9542857142857143,0.9960907708673042,1.0,7/11,43.50%,HK2;GNE;HK1;KHK;GALK2;POMK;HK3
prerank,ATP hydrolysis activity (GO:0140603),0.21382602603275802,0.5715283373393272,0.9595782073813708,0.9812911915367146,1.0,10/41,16.86%,ABCD2;TOR1B;ATAD1;DDX3X;RUVBL1;ABCB10;RHOBTB3;TOR1A;CHD1L;VWA8
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.21581374861281366,0.5702206289850029,0.9406631762652705,0.9791745197681565,1.0,9/40,14.67%,FBLL1;AS3MT;PCMTD2;THUMPD2;PRMT7;SETD3;METTL18;SUV39H1;GAMT
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.2104527497611896,-0.5698699447433939,0.9690721649484536,0.9943638518433746,1.0,2/23,5.85%,SESTD1;WIPI2
prerank,signal sequence binding (GO:0005048),-0.1876896194483551,-0.5669694213212237,0.9851694915254238,0.9926629833744977,1.0,8/35,22.64%,CEMIP;BRAP;KPNA6;NFKBIA;BABAM2;SEC61A1;NUP214;AP2M1
prerank,N-acyltransferase activity (GO:0016410),0.2244991269456405,0.5663205821531122,0.9594594594594594,0.9786606563383864,1.0,6/32,11.61%,BAAT;PLAAT1;CERS4;PLA2G4E;GLYAT;EP300
prerank,single-stranded RNA binding (GO:0003727),0.2103403885982236,0.5588719518939411,0.9798165137614679,0.9801252359833987,1.0,14/43,21.25%,ADARB2;AGO3;DDX3X;HNRNPA1;RBM7;HNRNPU;FMR1;DDX11;LACTB2;ZFR;ENDOV;POLR2D;EIF4H;PTBP1
prerank,histone acetyltransferase binding (GO:0035035),-0.2167312638183032,-0.5584589764844008,0.9571984435797666,0.9930950133556864,1.0,8/21,25.85%,STAT1;HIF1A;GLI3;MEF2A;SIRT2;EGR1;TRIP4;TP53
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.25710108784123253,0.5544175106566532,0.9341317365269461,0.9796397776624248,1.0,3/11,17.44%,NAA11;NAA30;NAA15
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.21470356275256905,-0.5490284108382508,0.9756592292089249,0.9936530461692024,1.0,2/18,7.81%,GAS6;BIRC3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.19350675896775898,-0.5468931697209268,0.9824561403508771,0.9915316386280071,1.0,13/28,39.93%,EDC3;PRORP;ELAC2;DICER1;RPP38;NUDT16;POP1;AGO2;EXO1;RPP21;FEN1;RPP40;MRPL44
prerank,3'-5' exonuclease activity (GO:0008408),0.20198492019566372,0.5394412321111615,0.9841269841269841,0.9847110485856208,1.0,12/45,17.93%,REXO2;PAN2;XRN2;RAD1;TRIR;REV3L;EXD1;DIS3L2;TATDN1;ERI2;APEX1;USB1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.2168732032403207,0.5368201381925743,0.9448669201520913,0.9830945277427294,1.0,6/28,16.09%,TRAF5;TRAF3;TRAF6;TRAF2;MADD;TRIM37
prerank,pseudouridine synthase activity (GO:0009982),0.23611023918638968,0.5307764956619612,0.957983193277311,0.9830458462848837,1.0,13/13,76.41%,TRUB1;PUS7;DKC1;RPUSD1;PUS10;PUS1;PUSL1;PUS3;RPUSD3;RPUSD2;RPUSD4;PUS7L;TRUB2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.1662412775967678,-0.5249596085264704,0.9956521739130435,0.9954450363106868,1.0,6/42,15.90%,KAT2B;CCND2;CCND3;CCNG1;CCND1;CDKN1B
prerank,ubiquitin binding (GO:0043130),-0.15130965374892671,-0.5243563007940298,1.0,0.9926967829283937,1.0,21/73,31.22%,SMAD3;TOM1L1;RNF185;USP5;DNAJB2;MDM2;SIRT2;NPLOC4;IKBKG;VPS28;UBE2L6;UBXN1;TOP2A;RNF19B;PRKN;NUP62;OTUB2;CXCR4;NEDD4;AUP1;HSPB1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.20294394429037324,0.5124264364879371,0.9706457925636007,0.9877783396737084,1.0,7/27,19.09%,POLR2C;POLR3H;MED20;POLR1A;POLR1B;POLR3F;POLR2D
prerank,transaminase activity (GO:0008483),0.24258512343642163,0.503763793831655,0.954248366013072,0.9881853990982201,1.0,2/11,10.85%,GOT1;PSAT1
prerank,aspartic-type peptidase activity (GO:0070001),-0.22582499725377775,-0.5029043402649135,0.9819494584837545,0.9949941438548633,1.0,3/10,31.85%,BACE2;CTSD;CTSE
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.233458882611425,0.498335774256222,0.971252566735113,0.9871838529696977,1.0,12/12,76.67%,DHRS4;CRYZL1;CBR1;CRYZ;NQO1;CBR4;NQO2;ADH4;AKR1C1;AIFM2;DCXR;NDUFS7
prerank,gamma-tubulin binding (GO:0043015),0.21665687481985102,0.497038552730932,0.9666666666666667,0.9847280595804019,1.0,6/21,19.21%,DDX3X;BRSK1;ARHGEF7;PAK1;MARK4;NDRG1
prerank,snoRNA binding (GO:0030515),-0.16617519137790512,-0.47467030661654114,0.9958592132505176,0.9971854126164577,1.0,11/30,36.28%,NUDT4;NOP58;UTP6;BYSL;NUDT16;NUDT1;NHP2;NUDT5;IMP4;BMS1;ISG20
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.1936653091129839,-0.46376965120288105,0.9869158878504672,0.9959225758512286,1.0,3/13,24.34%,ARHGDIA;SH3BP4;RANBP1
prerank,nuclear localization sequence binding (GO:0008139),-0.1744479143737674,-0.45326486938360916,0.9922178988326849,0.9942769196741255,1.0,4/18,20.51%,BRAP;KPNA6;NFKBIA;NUP214
prerank,ribonuclease P RNA binding (GO:0033204),0.2128420788350489,0.45200596757635864,0.9766949152542372,0.9941506991710333,1.0,10/10,78.73%,POP7;POP5;RPP30;POP4;RPP25;RPP14;RPP40;RPP21;POP1;RPP38
prerank,neuropeptide hormone activity (GO:0005184),0.1881909547738695,0.44936236932562296,0.9884615384615385,0.9918042002321849,1.0,22/22,81.21%,CCK;SPX;NPY;PNOC;OXT;CORT;QRFP;HCRT;GHRH;NPPA;UCN;CALCB;NPFF;GAL;CRH;VIP;NMB;ADCYAP1;GRP;PENK;AGRP;PPY
prerank,aspartic-type endopeptidase activity (GO:0004190),0.1716886377903327,0.37641321636230585,0.9978858350951374,0.9978521161444254,1.0,12/12,82.84%,PSEN1;HM13;SPPL3;SPPL2A;BACE1;PGC;DDI2;ASPRV1;NAPSA;SPPL2B;CTSE;BACE2
